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About this work  
 
This doctoral project aims to improve the overall knowledge on the 
effects of neurorehabilitation in People with Multiple Sclerosis (PwMS), 
by providing more insights on fatigue and the relationship between 
fatigue and motor functional aspects. 
The general introduction provides background information on the main 
topics of this doctoral project. In the first part, the specific disease 
characteristics of Multiple Sclerosis are described.  In the second part, 
the current status of fatigue and motor impairment and a focus on the 
management are presented. Finally, the aims and outline thesis are 
reported. 
Four studies were conducted and reported in  4 different chapters.   
The first study provides information about the cardiac autonomic function 
during rest, postural changes and exercise and the relationship between 
autonomic modulation of heart rate and the perceived fatigue. 
The second study investigates the effect of an experimental rehabilitation 
protocol which combines aerobic training and task oriented exercises 
aimed to reduce fatigue and improve upper limb impairments and 
function. 
The third study provides information about preliminary effects of a high-
intensity rehabilitative multimodal training protocol carried out on a 
treadmill aimed at improving mobility and balance. 
The fourth study shows the effectiveness of functional electrical 
stimulation on reducing falls, improving gait kinematics and promoting 
energy recovery. 
Lastly, general conclusions, including main findings and clinical 
implications, are provided at the end of the doctoral thesis. 
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Definition, pathogenesis and prevalence 
  
Multiple Sclerosis is a chronic inflammatory and neurodegenerative disease 
of the Central Nervous System (CNS) and it is the leading cause of non-
traumatic disability in young and middle-aged adults.1 Even though the 
pathogenesis of MS is only partly understood, it is believed that 
lymphocytic infiltration through the blood-brain-barrier into CNS leads to 
damage of myelin.1 In addition, it initiates a cascade of inflammatory 
reactions which also affect surrounding oligodendrocytes as well as 
microglia. This initial damage can be repaired as inflammation resides and 
remyelination of the affected axons occurs. However, whether 
remyelination is not suitable progressive and definitive damage of CNS 
occurs.1  
According to the WHO/MSIF MS Atlas, the disease affects 2.3 million 
people worldwide, with more than 600,000 cases in Europe.1 Since 1980, 
many epidemiological studies have classified Italy as a high-risk area for 
MS, with the highest rates in the island of Sardinia, and no evidences of a 
latitude gradient. According to the Italian MS patient society (AISM) 
estimates, there are 75,000 patients in Italy with an incidence of 2000 
cases per year. Applying these mean prevalence rates to the Italian 
population as of 2015, we obtained an estimate of more than 109,000 MS 
patients in Italy.2 
 
 
Diagnosis, sign, symptoms and progression 
 
The diagnosis of MS is made clinically. There is not a single test that can 
determine if a person does or does not have the disease. MS is a disease 
defined by neurological symptoms separated (or disseminated) in time and 
space. MS diagnosis is primarily based on the Poser criteria3 or the 
McDonald criteria.4  
According to Poser criteria is based on (1) number of relapse, (2) clinical 
and paraclinical symptoms, (3) chronic inflammation of the CNS as 
determined by the analysis of the cerebrospinal fluid. According to 
McDonald criteria, (1) clinical evidence of two attacks at different times 
(i.e. disseminated in time), (2) evidence of at least two different areas of 
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the CNS affected (i.e. dissemination in space), (3) chronic inflammation of 
the CNS as determined by the analysis of the cerebrospinal fluid. In 2010, 
the revisions to the McDonald Criteria emphasizes the use of MRI of the 
brain to support and to confirm diagnosis of MS and rule out alternative 
explanations for the symptoms, such as stroke, brain tumors or 
infections.5,6  
 
Clinically Isolated Syndrome (CIS) is now recognized as the first clinical 
presentation of a disease that shows characteristics of inflammatory 
demyelination that could be MS, but has yet to fulfill criteria of 
dissemination in time. MS phenotypes can be categorized as relapsing or 
progressive in the context of current medical status and history, but these 
categories do not provide temporal information about the ongoing disease 
process: relapsing remitting (RR), secondary progressive (SP), primary 
progressive (PP).6 
All forms of MS, with the exception of PPMS, are initially characterized by a 
pattern of relapses and remissions over time. A relapse is defined as the 
appearance of new symptoms or worsening or reactivation of previously 
present symptoms. The appearance or change in symptoms must last at 
least 24h, be separated from a previous relapse by at least 30 days, and not 
be the consequence of a change in body temperature or an infection. The 
specific course of MS that a person has will influence disease progression.6 
MS relapses are highly variable between individuals as well as in a given 
individual and over time. A person may experience a very mild relapse that 
allows him or her to continue to perform most daily activities.7  
 
Onset of MS most often occurs in adults between the ages of 20 and 50 
years, and is two to three times more common in women than men. The 
course of MS is heterogeneous, but generally evolves over 30–40 years, 
and is characterized by multiple neurologic deficits and significantly 
decreased quality of life (QOL), and leads to substantial disability in many 
patients.8 In a population-based study, 33% of 1099 people with MS had 
difficulty walking and required assistance at 10 years from onset of MS. 
Symptoms are also heterogeneous and may include optic neuritis, fatigue, 
weakness, gait ataxia, spasticity, muscle spasms, pain, tremor, numbness, 
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paraesthesia, bladder and bowel dysfunction, and cognitive deficits, among 
other problems.8 
Gait impairment is a clinical hallmark of MS, often resulting from the 
combination of multiple common symptoms and deficits such as fatigue, 
weakness, spasticity, ataxia, and balance problems.9 
Accordingly, measurement of walking ability is a major component of 
instruments widely used for evaluation of disease severity and progression. 
Although EDSS has been criticized for over-reliance on ambulation and lack 
of sensitivity to other problem, it still remains the widely used scale to 
evaluate and describe progression in MS.10  
The EDSS score is based on examination of eight body functions (called 
functional systems): pyramidal, cerebellar, brainstem, sensory, bowel and 
bladder, visual, cerebral, and walking. Typically, the EDSS score is 
determined by a neurologist’s clinical examination. The resulting score is an 
ordinal-level measure that extends from 0.0 (normal neurological exam) to 
10.0 (death from MS), see Figure 1. 
 
 
Figure 1: Expanded Disability Status Scale (EDSS) 
 
 
Treatment 
 
Pharmacological treatment of MS consists of treatment of relapse, disease-
modifying therapies, and symptomatic therapy. The standard regimen in 
treating relapse leading to a faster recovery by restoring blood-brain 
barrier leakage, reducing edema and dampening the inflammatory 
processes in CNS is the use methylprednisolone at high dose. Relapse 
 
 
10 
 
treatment with steroids probably has no long-term benefit on disease 
progression while disease modifying therapies have been shown to 
decrease relapse rate and slow clinical progression.11  
First-line disease-modifying drugs currently being used include beta-interferons 
(Avonex®, Betaferon®, Rebif®) and glatirameracetate (Copaxone®), whereas in 
those patients with very high disease activity or not responding to first-line 
agents, second-line treatment such as natalizumab (Tysabri®), mitoxantron 
(mitozantron), fingolimod (Gilenya®) has been introduce. These disease-modifying 
therapies are able only to decelerate disease progression, but cannot reverse 
existing lesions.12 
Currently, there are not approved pharmacological therapies for people 
with PPMS.13 Symptomatic pharmacological treatment may help to reduce 
the negative impact of MS symptoms (e.g. spasticity, pain, bladder and 
bowel dysfunction).9 
Despite established advancement of pharmacological treatment, especially 
by disease-modifying therapies, MS continues to be the most common 
disabling neurological disease in young adults. While a growing number of 
medications can reduce the number of relapses and alter the course of the 
disease, PwMS continue to experience restrictions in their ability to 
participate in activities daily living. Therefore, there is a continuing need for 
comprehensive, multidisciplinary, long-term management, which 
constitutes the basic concept of rehabilitation.12 
 
Rehabilitation is defined as a problem solving educational process aimed at 
reducing disabilities and handicaps (participation) experienced by someone 
as a result of a disease or injury.13 The principal focus of rehabilitation is on 
reducing symptoms and limitations at the level of activity and participation, 
through interventions which include personal and environmental factors, 
to achieve the highest possible independence and the best Quality of Life 
(QoL) of PwMS within the limits of the disease.14 
Multidisciplinary rehabilitation is designed to be patient-centered, time-
based, functionally oriented and aims to maximize activity and 
participation. The activity of a person with MS can be affected from a 
combination of motor (weakness, spasticity), sensory (proprioception loss, 
ataxia), fatigue, psychological and visual impairments. Improving or 
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restoring physical and psychosocial abilities therefore is a key issue in 
rehabilitation of PwMS.15 
 
 
Fatigue  
 
Fatigue is the most common symptom reported by people with MS and 
contributes to reduced walking capacity16 and experiencing problems in 
daily life, for example with grasping or lifting an object, due to upper limb 
dysfunction.17  
In a recent study LaRocca et al. interviewed 1011 PwMS and documented 
the most commonly reported MS symptoms experienced at least twice a 
week were fatigue (76%), abnormal sensation (60%) and loss of balance 
(54%) (Figure 2).11  
 
 
Figure 2: Multiple Sclerosis symptoms experienced at least twice a week by PwMS 
 
 
Moreover, of all PwMS, 412 (41%) reported difficulty walking saying that 
this problem not only negatively affected their mobility but also restricted 
their activities and affected their emotional health.11 (Figure 3 and 4)  
 
 
 
12 
 
 
 
 
Figure 3: Multiple Sclerosis symptoms experienced by PwMS 
 
 
 
 
Figure 4: Negative impact of difficulty walking on PwMS  
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Approximately 70-90% of PwMS experience fatigue and up to 40% of them 
describe it as their most disabling symptom. Even though the importance 
and clinical relevance of fatigue is evident, there is a lack of consensus 
regarding its definition and underlying theoretical construct. Multiple 
Sclerosis for Clinical Practice Guidelines defines fatigue as a subjective lack 
of mental or physical energy as perceived by the individual (or caregiver) to 
interfere with usual or desired activities.18 
Fatigue can be of sensory, motor, cognitive or subjective origin. MS fatigue 
can occur as a consequence of the disease process itself defined as primary 
fatigue. Current knowledge suggests there are three potential mechanisms 
for primary MS fatigue that are changes in the central nervous system 
(including axonal loss and cortical reorganization), changes in immune 
system and endocrine influences. Fatigue can be a consequence of other 
factors not directly related to the disease, secondary fatigue. Examples 
include sleep problems, medications, deconditioning, depression, stress 
and anxiety.19 
Chadhuri and Behan introduced a clinical approach to fatigue distinguishing 
central fatigue from peripheral fatigue, where central fatigue is defined as 
the inability to initiate and/or sustain attentional tasks (cognitive fatigue) 
and physical activities (physical fatigue). It is consistently seen with lesions 
in pathways associated with arousal, attention, reticular and limbic system 
and the basal ganglia. On the contrary, peripheral fatigue is defined as 
muscle fatigability due to abnormalities of muscle and neuromuscular 
junctions with an objective reduction in muscle strength measured as the 
rate of decline in peak force generated during maximal voluntary muscle 
contraction.20 
The lack of a uniform definition for MS-related fatigue, can be contributed 
to the multifaceted and complex pathophysiological mechanism. 
Therefore, fatigue is a critical symptom to address during rehabilitation 
because it may worsen other symptoms (e.g. cognition) or it may increase 
as a consequence of others (e.g. spasticity).21,22 
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Managing fatigue and motor impairment: Role of exercise  
The underlying mechanisms regarding the effects of exercise therapy on 
fatigue in MS are still poorly understood. Exercise therapy may increase the 
energy reserves available for physical work and alleviate the detrimental 
effects of physical inactivity. In addition, exercise therapy and/or physical 
activity in itself may enhance neurobiological processes that could promote 
neuroprotection and neuroplasticity and reduce long-term disability. 
Exercise therapy has the ability to induce changes in this neurobiological 
processes. Compared to pharmacological and non-pharmacological 
interventions such as energy conservation management and cognitive 
behavioral therapy, exercise may affect both primary mechanisms (e.g. 
neuroprotection or dysfunction), as well as secondary factors related to 
fatigue (e.g. inactivity or co-morbidity).23  
Level of physical activity is a key issue in the management of fatigue. 
Patients are likely to be sedentary because of associated disabilities (e.g. 
weakness and pain), reduced levels of physical endurance and 
deterioration of symptoms that could follow physical exertion. However, 
physical inactivity imposed by fatigue leads to chronic cardiovascular and 
muscle deconditioning and raised health risks. Input from therapists can 
help in assessment of the level of disability and to identify an acceptable 
range of daily physical activity to prevent physical deconditioning and 
resulting weakness and muscle atrophy.23  
It has been reported in a recent review by Heine et al. that exercise can be 
safely prescribed and is moderately effective in the treatment of fatigue in 
PwMS without increasing the number of relapses. He has also shown that 
these effects vary between studies and between participants. This review 
suggested that endurance training, mixed training, or ‘other’ types of 
training (e.g. yoga) may be more effective compared to muscle strength 
training and task-oriented training but it is too premature to consider a 
certain type of training superior to any other.22 
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Aim and thesis outline 
 
Aim  
The main topic of the present dissertation consists of the investigation into 
the effects of neurorehabilitation in individuals with multiple sclerosis 
(MS), focusing on fatigue and motor function. 
The main aim of this thesis is to investigate physiological and rehabilitative 
outcomes in order to identify whether there is any difference in 
physiological outcomes between healthy subjects and people with multiple 
sclerosis and the impact of exercise.  
Moreover, a second objective of this thesis is to find new rehabilitative 
strategies able to mitigate fatigue symptoms and motor dysfunctions in 
MS. Towards this goal, we evaluated the role of exercise.  
  
 
Thesis outline 
Here, we are presenting four studies focused on different aspects of 
neurorehabilitation concerning fatigue and motor function. 
 
Chapter 1 provides evidence about the differences in basal cardiac 
autonomic tone between healthy subjects and PwMS and its modulations 
while standing, during submaximal exercise and during the recovery phase 
after exercise. Moreover, the relationship between autonomic modulations 
of heart rate and the perceived fatigue in PwMS without clinically overt 
autonomic dysfunction was provided.  
 
Chapter 2 describes a crossover study investigating the effects of an 
intensive period of rehabilitation comprising a combination of endurance 
training and task-oriented training on fatigue and upper limb impairment in 
people with MS. The main result of this pilot study is that 8 weeks of 
neurorehabilitation can reduce fatigue and upper limb impairments 
without any improvement in manual dexterity. 
 
Chapter 3 extends the results of Chapter 2 to the impact of 
neurorehabilitation using endurance training and task oriented 
approaches. The present study examined the response of moderately to 
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severely affected PwMS to an in clinic intensive multimodal training on a 
treadmill and compared it to a control group that received a strengthening 
program of similar intensity. The main result of this study is that many 
more people in the treadmill group improved their gait resistance than in 
the strength training group and as a whole the group improved much more 
in gait resistance, speed and mobility. 
 
Chapter 4 describes prospective longitudinal study investigating the role of 
using functional electrical stimulation on improving gait parameters and 
walking endurance in neurological conditions. We found a period of 8 
weeks of walking training with the use of a functional electrical stimulation 
device had an impact on gait, reducing the number of falls and improving 
walking. Moreover, we observed a specific effect at the ankle joint, 
increasing foot clearance during the swing phase of gait without a 
concomitant reduction in the energetic expenditure during walking in 
subjects with neurological conditions. 
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Chapter 1 
 
 
 
CARDIAC AUTONOMIC FUNCTION DURING POSTURAL 
CHANGES AND EXERCISE IN PEOPLE WITH MULTIPLE 
SCLEROSIS: A CROSS-SECTIONAL STUDY 
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Abstract  
 
Background. People with multiple sclerosis (PwMS) often develop an 
autonomic dysfunction (AD), which onset should be assessed early at a 
sub-clinical level, as it may interfere with pharmacological treatments and 
exercise. 
Objective. To evaluate basal cardiac autonomic tone, its modulations 
during sit-to-stand, sub-maximal exercise and recovery in PwMS without 
clinical overt AD and its relationships with fatigue perception. 
Methods. Twenty-three PwMS (55±8 yrs [mean±SD]; EDSS score 5.7±1.3) 
and 20 age-matched healthy controls (HC; 55±8yrs) were enrolled. ECG was 
digitally acquired at baseline (sitting and standing), during a light upper-
limb cyclic exercise and during sitting recovery. Parasympathetic and 
sympatho-vagal parameters of heart rate (HR) variability in time and 
frequency domains were calculated from beat series.  
Results. HR was slightly higher but not significantly different in PwMS 
compared to HC in all experimental conditions. Parasympathetic indexes 
were significantly lower (P<0.05) in PwMS compared to HC during baseline 
sitting and exercise recovery, whereas sympatho-vagal parameters were 
similar in both groups. No correlation between autonomic tone and 
perceived fatigue was observed.  
Conclusion. Parasympathetic tone appears to be impaired in PwMS basal 
and post-exercise conditions, but not during postural challenge and 
exercise. In addition, subclinical AD doesn’t seem to affect perceived 
fatigue. 
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Introduction 
 
Multiple Sclerosis (MS) is a chronic central nervous system disease that 
may affect autonomic function. The demyelination of specific structures 
causes bladder, bowel and sexual dysfunction, leading to disability in 45-
84% of PwMS and dramatically impacts quality of life.1  
 
The effects of sympathetic and parasympathetic disturbances on hearth 
function in PwMS are not fully understood. A cardiovascular autonomic 
dysfunction (AD) has been demonstrated in variable proportions of 
patients,1, 2 ranging from 7 to 60%,1 and appears to correlate with the 
severity and the duration of the disease. However, it is not clear when AD 
arises in the course of MS development. Therefore, the importance of 
autonomic function testing in detecting early subclinical changes in PwMS 
has been highlighted2 to set an adequate prevention therapy, based on 
drug interventions or exercise. 
A validated method to study cardiac autonomic activity is the analysis of 
spontaneous Heart Rate Variability (HRV), which can be easily used to 
evaluate the cardiovascular autonomic reactions to common everyday 
motor tasks, such as light exercise and postural challenges. So far, the 
studies evaluating autonomic HRV modulations in PwMS have used classic 
clinical autonomic tests in supine position and during sleep3, 4  or long-term 
heart activity recording based on 24-h ECG monitoring.5 However, no 
studies investigated vagal or sympathetic modulations of HR during 
orthostatic challenges and continuous exercise in PwMS.  
 
Moreover, an altered cardiac autonomic response might be one of the 
reasons for an impaired tolerance to exercise or everyday life activities: 
however little information is available on the relationship between 
subjective fatigue perception and the autonomic modulation of HR in 
functional situations in PwMS.  
Finally, the assessment of autonomic responses is of particular interest for 
patients undergoing pharmacological treatments (e.g. fingolimod) 6 
potentially interfering with cardiovascular function and may help to 
optimize physical activity prescription for PwMS, with important 
implications in terms of clinical outcomes. 
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The aims of this study were therefore to evaluate basal cardiac autonomic 
tone and its modulations during standing, continuous submaximal exercise 
and recovery and assess whether a relationship exists between autonomic 
modulation of HR and the perceived fatigue in PwMS without clinical overt 
AD. 
 
 
Materials and Methods 
 
Study design and participants 
Our cross-sectional study conducted from January 1 2016 to July 30 2017 
recruited Healthy Control (HC) subjects and PwMS from the hospital and 
ambulatory services of [masked]. The study involved PwMS meeting the 
following inclusion criteria: having a confirmed MS diagnosis (according to 
revised McDonald criteria)7, age>18 years, free from relapses or relapse-
related treatments for three month before the study and from any medical 
conditions that could interfere with the autonomic cardiovascular control.  
The study was conducted in accordance with the Declaration of Helsinki 
and approved by the local Ethics Committee of the Don Gnocchi 
Foundation. Each subject gave an informed consent to participate.  
 
Experimental protocol  
All subjects underwent clinical examination, including measurements of 
resting blood pressure and a standard 12-lead ECG. Co-morbidities, 
medications, disease severity and disease duration were documented. 
Participants were asked to stop alcohol, coffee and smoking 2 hours before 
testing.  
ECG was digitally acquired by a wearable sensor1, in a clinical rehabilitation 
setting, during the following conditions: 1) baseline: 5 minutes, sitting at 
rest in a comfortable position; 2) standing: 2 minutes, using a hand support 
to maintain balance; 3) exercise: 4 minutes, performing submaximal upper 
limb cyclic aerobic exercise at 5-10 watt power, in sitting position4 using an 
arm ergometer2 ; 4) recovery: 2 minutes, sitting.  
                                                          
1
 Faros 180, Finland 
2
 Monark 881E, Sweden 
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At the end of each experimental phase the rate of perceived exertion (RPE) 
was recorded using the Borg scoring system, ranging from 6 to 20, where 6 
means ‘no exertion at all’ and 20 means ‘maximal exertion’. This scale is 
validated for healthy individuals8 and has also been used to assess exertion 
in PwMS.9 In particular, participants were asked about the RPE of breath 
(Breath_RPE) and upper limb (UL_RPE) at the end of each experimental 
phase.  
 
Outcome measures 
ECG recorded signals were firstly visually inspected, in search for artifacts 
or premature beats, which were manually removed. HRV parameters were 
then calculated by Kubios HRV 2.2 software (Kuopio, Finland), using 
validated methods in the time and frequencies domains.10  
Autonomic function was assessed as follows: 
- The Root Mean Square of Successive Differences between consecutive 
beats (RMSSD, ms) and the percentage of consecutive beats differing>50 
ms (pNN50, %) from each other were assessed as indexes of 
parasympathetic activity;10 10 
- The High Frequency (0.15–0.4 Hz) band of heart rate power spectrum, 
expressed in absolute units (HF, ms2) was evaluated as an index of 
parasympathetic activity;10  
 
- The Low Frequency (LF, 0,04-0,15 Hz) band, expressed in normalized units 
(LFnu = Total power/LF power) was used as an index of modulation of the 
sympathetic branch of the autonomic nervous system.10 
- The Low to high frequency ratio (LF/HF) was calculated as a marker of the 
sympatho-vagal balance.10  
 
Finally, the ECG derived respiratory frequency (EDR, Hz) was used to 
estimate the respiratory frequency.11  
 
Statistical analysis  
Descriptive statistics were provided on the demographic and baseline 
clinical variables in the entire sample and for each group separately and 
were used to detect the presence of outliers. Data were not normally 
distributed according to the Shapiro–Wilks test; thus, Box Cox 
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transformations were applied,12 to improve the normality of the following 
transformed (t) variables: RMSSD, HF, pNN50, LFnu, LF/HF and EDR. T-test 
or Chi-squared test or Mann-Whitney U test were used when appropriate 
to detect differences between groups.  
Repeated measures ANOVA and planned comparisons were used to 
determine differences between groups in different experimental 
conditions.  
Spearman’s correlation coefficients were computed between RMSSDt,, 
EDSS and disease duration at baseline and between RMSSDt and UL_RPE, 
EDR and Breath_RPE t during exercise in PwMS. All analyses were 
performed using Statistica software (ver. 9.0, Tulssa, USA) and the P level 
was set at 0.05. 
 
 
Results  
 
Demographic, clinical and baseline parameters 
The study included a total of 43 subjects, i.e. 20 healthy control (HC) 
subjects and 23 PwMS. At the time of the study, 3 HC subjects were 
receiving anti-hypertensive drugs (other than ß-blockers, which could 
interfere with HRV analysis), 2 HC subjects were under pharmacological 
treatment for hypercholesterolemia and other 2 HC individuals were 
receiving thyroid medications (and were in documented euthyroidism); 7 
PwMS were under disease modifying drugs, 1 subject was receiving 
anticonvulsant treatment and 1 subject was being treated with 
antidepressants.  
None of the subjects was presenting clinical signs of overt AD (postural 
intolerance, tachycardia, etc.). 
One HC subject was removed from the subsequent analysis as outlier, due 
to unstable hypertensive values of blood pressure at the baseline 
evaluation, and 1 subject with MS was removed from the analysis due to 
the presence of complex and frequent cardiac arrhythmias at the basal ECG 
recording. Descriptive demographic and clinical characteristics of the 
remaining enrolled subjects (n=41), along with the baseline values of HR 
and blood pressure are reported in Table 1. No statistically significant 
difference was found between HC and PwMS groups. 
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Table 1. Clinical and demographic characteristics of the samples 
(mean±SD).  
 
HC (n=19) PwMS (n=22) P value 
Age (years) 54.5 ± 7.9 55.4 ± 9.4 n.s. 
Sex (F/tot) 14/19 14/22 n.s. 
EDSS / 5.7 ± 1.3 - 
Disease duration (years) / 15.1 ± 10.3 - 
Mean resting HR (bpm) 73 ± 8 79 ± 10 n.s. 
Systolic Blood Pressure 
(mmHg) 
125 ± 16 118 ± 14 n.s. 
Diastolic Blood Pressure 
(mmHg) 
80 ± 11 80 ± 8 n.s. 
 
EDSS: Expanded Disability Status Scale; HR: Heart Rate; HC: Healthy Control 
subjects; PwMS: People with Multiple Sclerosis; n.s.: not statistically 
significant. 
 
HR and HRV assessment: comparing HC and PwMS 
Figure 1 shows baseline HR values and HR responses to standing, exercise 
and recovery in both groups. Two-way repeated measure analysis of 
variance (ANOVA) reported slightly higher but not significantly different HR 
in PwMS in all experimental conditions (Group: p=0.17; Condition: p<0.01; 
Interaction: p=0.29). 
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Figure 1. Heart rate (mean ± SD) at baseline and during standing, exercise 
and recovery in Healthy Control subjects and in People with Multiple 
Sclerosis.  
 
 
 
 
HR: Heart Rate; HC: Healthy Control subjects; PwMS: People with Multiple 
Sclerosis. Whiskers represent standard deviations. 
 
Absolute values of HRV variables at baseline are reported in Table 2. Basal 
values of the parasympathetic indexes (RMSSD, pNN50 and HF power) 
were significantly lower (p<0.01 for all comparisons) in PwMS. Conversely, 
the indexes of sympathetic activity (LFnu), sympatho-vagal balance (LF/HF) 
and baseline EDR values did not differ between groups.   
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Table 2. Absolute values (mean±SD) of Heart Rate Variability parameters 
and ECG Derived Respiration estimate in Healthy Control subjects and in 
People with Multiple Sclerosis at baseline.  
 
RMSSD: Root Mean Squared Difference between adjacent R-R intervals; 
pNN50: percentage of normal beats differing for >50 ms from the 
preceding normal beat; HF: Absolute HF  (High Frequency [0.15-0.40 Hz]) 
power of HR power spectrum; LFnu: LF (Low Frequency [0.04-0.15 Hz]) in 
normalized units; LF/HF: Ratio between LF and HF powers; EDR: ECG 
derived respiratory frequency (Hz); HC: Healthy Control subjects; PwMS: 
People with Multiple Sclerosis; n.s.: not statistically significant. 
 
 
 
Table 3 shows the results of a 2-way repeated measures ANOVA on HRV 
transformed variables in each experimental condition with clinical 
conditions (HC, PwMS) as group factors and experimental conditions as 
repeated factors: significant overall interactions were found for RMSSDt, 
pNN50t and HFt. 
 
 
 
 
HC (n=19) PwMS (n=22) P value 
RMSSD (ms) 24.1 ± 9.6 17 ± 6.4 <0.01 
pNN50 (%) 5.2 ± 5.0 1.2 ± 2.4 <0.01 
HF (ms2) 222 ± 184 87 ± 81 <0.01 
LFnu 69.7 ± 15.1 72.5 ± 16.1 n.s. 
LF/HF 3.3 ± 2.4 4.0 ± 2.7 n.s. 
EDR (Hz) 0.23 ± 0.1 0.23 ± 0.1 n.s. 
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Table 3. Two-way analysis of variance (ANOVA) for repeated measures on 
Heart Rate Variability (HRV) parameters and ECG Derived Respiration (EDR) 
estimate, with clinical conditions as levels and experimental conditions as 
factors. Significant values are reported in bold. 
 
 Group Condition Interaction 
RMSSDt  0.01 <0.01 0.01 
pNN50t <0.01 <0.01 0.01 
LFnut 0.31 <0.01 0.67 
HFt 0.02 <0.01 0.04 
LF/HFt 0.36 <0.01 0.78 
EDRt 0.50 <0.01 0.45 
 
RMSSDt: transformed values of Root Mean Squared Difference between 
adjacent R-R intervals ; pNN50%t: transformed values of the percentage of 
normal beats differing for >50 ms from the preceding normal beat >50; 
HFt: transformed values of absolute HF power (High [0.15-0.40 Hz] 
Frequencies) of HR power spectrum; LFnut: transformed values of LF (Low 
[0.04-0.15 Hz] Frequencies) power in normalized units; LF/HFt: 
transformed values of ratio between LF and HF powers; EDRt: transformed 
values of ECG derived respiration. 
 
 
Figure 2 shows HRV transformed variables (RMSSDt, pNN50t, HFt, LFnut) in 
HC subjects and in PwMS at baseline and during standing, exercise and 
recovery. Basal values of the parasympathetic indexes (RMSSDt, pNN50t 
and HFt power) remained significantly lower (P<0.01 for all planned 
comparisons) in PwMS compared to HC, whereas the indexes of 
sympathetic activity (LFnut) were similar in both groups.  
Surprisingly, during standing and exercise none of the HRV parameters 
significantly differed between PwMS and HC subjects, with the only 
exception of RMSSDt, which was significantly lower (P<0.05) in PwMS 
during standing only. 
Similar to the baseline values, post-exercise recovery of the 
parasympathetic indexes RMSSDt and pNN50t were significantly lower 
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(p<0.05 for all comparisons) in PwMS with no differences between groups 
in LFnut.  
 
 
Figure 2. Heart Rate Variability variables (m ± SD) in Healthy Control  
subjects and in People with Multiple Sclerosis at baseline and during 
standing, exercise and recovery.  
 
 
RMSSDt: transformed values of Root Mean Squared Difference between 
adjacent R-R intervals; pNN50t: transformed values of the percentage of 
normal beats differing for >50 ms from the preceding normal beat; HFt: 
transformed values of absolute HF (High [0.15-0.40 Hz] Frequencies) power 
of HR power spectrum; LFnut: transformed values of LF (Low [0.04-0.15 Hz] 
Frequencies) power in normalized units. Whiskers represent standard 
deviations. *: P<0.05; **: P<0.01 between groups comparisons.  
 
 
RPE assessment 
Table 4 shows the results of UL_RPE and Breath_RPE measured in baseline, 
orthostatism, exercise and recovery for HC and PwMS. We found 
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statistically significant differences between groups in all conditions with 
the exception of Breath_RPE during the exercise.  
 
Table 4. Rate of Perceived Exertion (mean ± SD) parameters related to 
upper limbs and breath in Healthy Control subjects and in People with 
Multiple Sclerosis in each condition.  
 
 
HC: Healthy Control subjects; PwMS: People with Multiple Sclerosis; 
UL_RPE: Rate of Perceived Exertion of Upper Limbs; Breath_RPE: Rate of 
Perceived Exertion of Breath; n.s.: not statistically significant. 
  
Relationship between clinical features and HRV parameter in PwMS  
No correlations were found between baseline RMSSDt and EDSS (r=0.23, 
p=0.30) nor between baseline RMSSDt and disease duration (r= -0.28, 
p=0.24). Similarly, no correlations were observed during exercise between 
 
 Score  HC PwMS P value 
Baseline 
UL_RPE  6.0 ± 0.0 7.4 ± 2.1 <0.01 
Breath_RPE  6.0 ± 0.2 7.1 ± 1.8 <0.01 
Orthostatism 
UL_RPE  6.4 ± 1.6 8.1 ± 2.5 <0.01 
Breath_RPE  6.0 ± 0.2 9.1 ± 2.9 <0.01 
Exercise 
UL_RPE  10.3 ± 3  14.5 ± 3.0   <0.05 
Breath_RPE  12.7 ± 2.8 11.6 ± 3.4 n.s. 
Recovery 
UL_RPE  8.4 ± 2.4 11.6 ± 3.1 <0.01 
Breath_RPE  7.4 ± 1.6 9.8 ± 2.7 <0.01 
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RMSSDt and UL_RPE (r=0.02, p=0.91) nor EDRt and Breath_RPE (r= -0.03, 
p=0.87). 
 
 
Discussion  
 
The main findings of our study are the following: 1) basal HR and its 
modulation during submaximal exercise and postural challenges did not 
differ between PwMS and HC subjects, although it tended to be higher in 
PwMS; 2) the parasympathetic cardiac autonomic tone appears to be 
affected at rest and during post-exercise recovery in PwMS, though in 
absence of clinical signs of overt AD; 3) although the upper limbs and 
breath perceived fatigue were significantly higher in PwMS in almost all 
conditions, no correlation was found between parasympathetic 
modulations of HR and fatigue during exercise.  
 
HR data showed slightly higher but not significantly different values (about 
5-10 bpm, on average) in PwMS in comparison to HC in all experimental 
conditions. We chose a submaximal exercise, along with the postural 
challenges of the sit-to-stand movement, because it mimics the usual 
exertion observed in everyday activities (light house works, stair climbing, 
rising from a chair, using the wheelchair, etc.). Higher HR values during 
submaximal efforts may suggest a reduced efficiency of cardiac pump in 
adapting cardiac output to a required task and are generally due to the 
cardiovascular deconditioning, which is known to affect PwMS. Since 
cardiac autonomic dysfunction was observed in this study in resting and 
recovery conditions only, it is unlikely that it could have affected the 
cardiovascular response to exercise and postural changes. Our data seems 
therefore to confirm what was found by Feltham, who demonstrated that 
the submaximal adaptation of HR to exercise is more affected by 
deconditioning rather than by autonomic dysfunction in PwMS.13  
 
At baseline, we found lower values of the parasympathetic indexes in 
PwMS compared to HC subjects, whereas the indexes of sympathetic and 
sympatho-vagal balance did not differ between groups: this suggests a 
subclinical impairment of the cardio-vagal system in long lasting PwMS, 
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confirming previously published results.14,15,16,17 The appraisal of existing 
literature and our results suggest that  subclinical AD involvement may vary 
during the course of the disease, at the beginning involving the 
sympathetic system and chronically evolving in a prevalent 
parasympathetic deficiency. The lack of correlation between the vagal 
indexes and the EDSS score, in accordance with the results by Videira,18 
suggests that parasympathetic AD in PwMS is more related to disease 
duration rather than to disability.  
Interestingly, during orthostatic challenge and exercise, the difference in 
parasympathetic indexes of HRV between PwMS and controls completely 
disappeared. During sit-to-stand transition and during exercise the cardio-
vagal system needs to be inhibited, in order to sustain the necessary 
increase in HR. Therefore, the capacity of inhibition of the vagal tone in 
PwMS seems to be preserved. It is noteworthy that, although not 
significantly, the sympathetic activation due to postural change and 
exercise, as reported by the HRV index LFnu, showed a trend towards an 
increase in each condition in PwMS with respect to HC subjects (Figure 4). 
Further studies are needed to infer whether a compensatory increase in 
the tone of sympathetic system occurred in our PwMS. However, Heesen 
et al. did not find any difference in norepinephrine concentration during 
exercise in PwMS.19 
The reduced post-exercise HR recovery is currently considered a 
cardiovascular risk factor: our data suggests a blunted post-exercise HR 
recovery in PwMS (although not significant compared to HC), this impaired 
recovery is probably not linked to impairment in HR adaptation to exercise 
since both groups reached similar values of HR at the end of the exercise 
(about 100 bpm), but it seems more associated with an impaired recovery 
of parasympathetic indexes in PwMS, as demonstrated by the significantly 
reduced values of RMSSD and pNN50. A different HR adaptation during the 
first 2 minutes of post-exercise recovery has been observed in PwMS also 
by Collett and coworkers,20 especially after a sub-maximal effort (45% of 
Watt peak), like the one used in our study. This is of particular clinical 
relevance, considering the high number of submaximal efforts required by 
everyday life activities (e.g. orthostatic challenges, light manual works etc.), 
which may enhance fatigue accumulation in PwMS.  
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Finally, upper limb fatigue perception was significantly higher in PwMS in 
all experimental conditions. However, the lack of relationship during 
exercise between the autonomic parameters and perceived fatigue may 
suggest that fatigue is due to central factors more than cardiovascular 
activation. These results agree with those of Merkelbach et al., who found 
no relationship between fatigue perception and autonomic function.21 
Similarly, the perception of respiratory fatigue differed between groups in 
all conditions except exercise, although the respiratory frequency both at 
rest and during orthostatic and exercise challenge, as estimated by EDR, 
was similar between groups. This deserves further examination of 
pulmonary function adaptation to exercise in PwMS. 
 
Finally, we acknowledge some limitations of our study. Firstly, the 
relatively small number of participants makes it difficult to generalize 
results. Secondly, the period of post-exercise analysis was very short, and 
therefore was not suitable to study long-term adaptation of HR or a 
possible carry-over effect of fatigue on cardiovascular recovery. Thirdly, the 
HRV method to investigate the autonomic control of HR does not represent 
the gold standard in evaluating the sympathetic tone, which is based on 
the micro-neurographic assessment of the peripheral autonomic nervous 
traffic. However, some parameters as LFnu and LF/HF are known to change 
when the interplay between parasympathetic and sympathetic system 
changes, therefore producing an estimate of the relative activation of the 
adrenergic system.  
Fourthly, no typical clinical testing of AD was performed on our patients, as 
these data was already reported in each clinical record. Finally, no plasma 
catecholamine concentration measure was performed in this study. 
  
 
 
Conclusions 
 
To the best of our knowledge, this is the first study integrating basal and 
functional measures of cardiac autonomic tone to evaluate the presence of 
subclinical AD in PwMS and evaluating how this may have an impact on 
cardiovascular responses to everyday life activities, as light exercise and 
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postural challenges. Parasympathetic basal tone and post-exercise 
reactivation appear to be impaired in PwMS, but HR modulation during 
postural challenge and exercise seems to be preserved. Furthermore, 
subclinical AD doesn’t seem to affect perceived fatigue. 
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EFFFECT OF NEUROREHABILITATION ON FATIGUE AND 
UPPER LIMB PERFORMANCE IN MULTIPLE SCLEROSIS: 
RANDOMIZED CROSS-OVER STUDY 
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Abstract  
 
Background. People with multiple sclerosis (PwMS) exhibit fatigue and 
sensory-motor upper limb impairments even in the early stages of the 
disease. Rehabilitation is a viable way to reduce fatigue and sensory-motor 
impairments. 
Objective. We designed an experimental rehabilitation protocol which 
combines aerobic training and task oriented exercises aimed to reduce 
fatigue and improve upper limb function. 
Study Design. Randomized Crossover Study 
Methods. Twenty PwMS received 20 treatment sessions lasting one our 
comprising of 30min of Aerobic Training and 30min of Task-oriented 
exercises for upper limbs. Fatigue was measured by Modified Fatigue 
Impact Scale (MFIS) and Rate of finger tapping at Maximum velocity during 
a fatiguing task (RATE-MV). Manual dexterity was measured with Nine Hole 
Peg Test (NHPT). The differences between treatment effects was assessed 
by a standard T-test, for continuous variables and Mann Whitney Test 
(MW) for independent samples using the intra-individual differences 
between the outcomes at the end of both periods as dependent variables. 
We checked for carryover effects summing up the values measured at the 
end of both periods for each subject and comparing the two groups by 
means of another T or MW test.  
Results. After protocol subjects showed a statistically significant reduction 
(p<0.05) in MFIS (-5 points) and RATE-MV (+0.17 HZ) without any carryover 
effect (respectively, p=0.63 and p=0.86). Manual dexterity (NHPT) showed 
no statistically significant treatment effect (+3.6s, p=0.63) after the 
rehabilitation period without any carryover effect (p=0.67). 
Conclusion. A combined aerobic and task oriented training positively 
reduces fatigue without improving manual dexterity. This suggests to 
clinicians a beneficial role of rehabilitation on fatigue on upper limb but 
tailored and more intensive interventions are needed to reduce manual 
dexterity disorders. 
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Introduction 
 
Multiple Sclerosis (MS) is a neurodegenerative, demyelinating disease that 
affects mostly young and middle-aged people. The multiplicity of physical 
and psychological dysfunctions has been shown to exhibit a high number of 
impairments such as fatigue, weakness, alteration of upper extremity and 
lower fine motor coordination, affecting activities of daily life and 
participation.1, 2 
Approximately 70-90% of People with Multiple Sclerosis (PwMS) 
experience fatigue defined as a “subjective lack of mental or physical 
energy as perceived by the individual (or caregiver) to interfere with usual 
or desired activities”.3 Moreover, approximately 70% of PwMS exhibit 
sensory-motor upper limb impairments such as reduced manual dexterity 
and sensitivity, muscle weakness, slowness of movements and tremor 
involving either one or both limbs even in the early stages of the disease.4,5  
 
Rehabilitation is a viable way to reduce fatigue and sensory-motor 
impairments. Studies on rehabilitation interventions and exercise therapy 
have proven to be safe and effective to reduce fatigue, with potential 
effects on cardiorespiratory fitness, promoting brain plasticity in PwMS.6 
Aerobic exercise may reduce the effects of deconditioning increasing 
physical fitness, general health lowering the incidence of comorbidity7 and 
it may positively affect neuroprotection, normalize hypothalamic-pituitary-
adrenal axis imbalances, and reduce inflammation.8 In addition, it has been 
recently suggested that aerobic exercise can be used as a priming 
technique to enhance cortical activation promoting motor relearning.9 It 
has been reported that a single bout of aerobic exercise on brain function 
improves functional connectivity10,11 enhancing the ability to learn and that 
these positive effects can persist after 30 minutes after the exercise 
suggesting that physical activity could promote brain plasticity in healthy 
subjects in motor and non-motor areas.12  
Priming the motor system before rehabilitation to improve upper limb 
function has been supported by Stinear in stroke population.13 However, 
the use of these strategies to prime the motor system is under explored in 
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PwMS since it is well known that aerobic training can have beneficial effect 
on cognition and brain function in this population.14  
Aerobic exercise can be used in rehabilitation to reduce fatigue and to 
prime the brain and to warm up upper limbs by performing task oriented 
exercises. However, the combination of aerobic training and upper 
functional exercises has not yet been explored. Recently, a review reported 
that motor rehabilitation can have a small but clinically relevant impact on 
upper limb function.15 Further, it has been demonstrated that task-
oriented exercises seem to be more efficient than passive mobilization 
preserving white matter microstructure and potentially induce a slight 
improvement in the activation of areas in the brain.16  
Despite current evidences supporting the positive effects of aerobic 
training, no studies have investigated the impact of a combination of 
aerobic and task-oriented exercises to boost the effect of upper limb 
rehabilitation in disable PwMS. Thus, in the present crossover study we 
designed a 8-weeks experimental rehabilitation protocol which combines 
aerobic training and task oriented exercises aimed to reduce fatigue and 
improve upper limb function.  
 
 
Materials and method  
 
Study design and Participants  
Our cross-over study included a total of 22 People with Multiple Sclerosis 
(PwMS). The eligible population included all PwMS residing in the centers’ 
catchment areas requiring rehabilitation. We recruited PwMS meeting the 
following inclusion criteria: having a confirmed MS diagnosis (by a 
neurologist), age >18 years old, free from relapses or relapse-related 
treatments for three month before the study, Expanded Disability Status 
Scale (EDSS) > 8. We excluded individuals unable to follow test instructions 
(e.g. with cognitive impairment or language barrier), having other diseases 
interfering with the execution of tests (e.g. psychiatric or orthopedic 
disorders), or affected by cardiovascular diseases.  
The study was approved by the Ethics Committee of the Don Gnocchi 
Foundation and each subject gave the informed consent to participate.  
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Subjects who met all the eligibility criteria underwent study assessment 
and were randomly assigned in a 1:1 ratio to counterbalanced groups 
(group A and B) by computer-generated random numbers. In agreement 
with a previous study on rehabilitation in MS17 Group A started a 8-week 
period of rehabilitation (intervention period, T), followed by a 8-week 
period without any intervention or specific training (waiting list period, 
WL). Group B was given the treatment in reverse order. (Figure 1) 
 
 
 
Figure 1: Flow chart shows the study protocol 
 
 
AT: Aerobic Training; To: Task-oriented training; T0: baseline assessment; 
T1: assessment after 8 weeks; T2: assessment after 8 weeks; T: Treatment 
period; WL: Waiting list period. 
 
Assessment procedures 
Participants were assessed with clinical evaluation at baseline (T0), at the 
end of the first 8-week period (T1) and at the end of the 8-week period 
(T2). (Figure 1) 
Each assessment was performed by a blind physical therapist. 
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Clinical assessment  
 
Fatigue 
Modified Fatigue Impact Scale (MFIS) is our primary outcome. Trait fatigue 
has been defined as a more stable state in an individual that is not likely to 
change over time18 measured by Modified Fatigue Impact Scale (MFIS) that 
is a structured, self-report questionnaire designed to assess physical and 
mental fatigue. This tool contains 21 items, which were scored from 0 
(never) to 4 (almost always), thus ranging from 0 (indicates no fatigue) to 
84 (indicates higher fatigue).19  
To understand whether a reduction in reported fatigue is accompanied 
with a reduction of motor fatigue we assessed finger movement rate in a 
fatiguing task. The assessment was performed using an engineered glove3 
to quantify finger motor performance accuracy; this simple and objective 
method has been recently demonstrated to be able to discriminate healthy 
controls and PwMS even with very low disability.20 Specifically, subjects 
were asked to perform with their eyes closed repetitive finger opposition 
movements of thumb to index, medium, ring and little fingers, with the 
affected hand at their maximal velocity. From the raw data recorded by the 
glove system, the movement rate [Hz] at maximum velocity (RATE-MV) has 
been extracted. 
 
Upper limb function  
Our primary outcome for manual dexterity was measured with the Nine 
Hole Peg Test (NHPT).21 
 
Secondary outcomes: 
Heart rate (HR) was used to assess the physiological aspects and 
adaptations related to the effort. HR was monitored at the end of arm 
ergometer exercise (HR). Participants performed 4 minutes of submaximal 
exercise at 10w intensity. Exercise was performed in sitting position using 
an arm ergometer4. State fatigue that is defined as a transient condition 
which can change with time and can fluctuate based on internal and 
                                                          
3
 Peregrine ETT 
4
 Monark 881E 
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external factor.18 The Borg scale was used to monitor the rate of perceived 
exertion (RPE) during the exercise testing. RPE is defined as subjective 
effort intensity and fatigue during physical exercise. RPE of breath 
(Breath_RPE) and upper limb (UL_RPE) were monitored at rest (baseline) 
and at the end of the submaximal exercise. The Borg Scale ranges from 6 to 
20, where 6 means “no exertion at all” and 20 means “maximal exertion”.22  
The Action Research Arm Test (ARAT) was performed to rate individual 
ability to grasp and lift objects of various sizes. It consists of 19 items 
organized into Grasp, Grip, Pinch and Gross Motor subsections. The Score 
ranges from 0 (bad upper limb function) to 57 (normal upper limb 
function).21  
Maximal isometric handgrip strength was measured in Newton using an 
hand-held CITEC5 digital dynamometer. 21 
 
Hospital Anxiety and Depression Scale (HADS) is a 14-item tool to measure 
the anxiety (7 items) and depression (7 items). A higher score represents 
higher levels of anxiety and depression: a domain score of 11or greater 
indicates anxiety or depression and 7 or lower indicates no signs of anxiety 
or depression.23  
 
Intervention  
PwMS received 15-20 one hour treatment sessions comprising of  30min of 
Aerobic Training and 30min of Task-oriented rehabilitation for upper limbs. 
Aerobic Training was performed in sitting position using an arm ergometer 
following the recommendations for PwMS in which subjects were 
encouraged to maintain an intensity of 11 and 12 points of RPE during 
aerobic exercise.24 
Task-oriented training comprised an active protocol based on voluntary 
unimanual and bimanual exercises for neuromuscular control to improve 
proprioceptive sensibility, muscle strength, stability and coordination of 
the upper limbs, mainly including task-oriented exercises with the goal to 
improve activities of daily living.25 The treatment dealt with such as 
manipulating and grasping wooden cubes or balls of different sizes, 
                                                          
5
 http://www.citec.nu/frm/uk.htm. 
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pinching objects with unimanual and bimanual exercises (e.g. grab a bottle, 
fill a glass of water, hang out clothes). 
 
 
Statistical analysis 
Descriptive statistics were provided on the demographic and clinical 
variables in the entire sample and for each group separately. Means (with 
standard deviations), medians (with interquartile ranges, IQR) and 
Percentage were used as appropriate. Parametric and non parametric tests 
were used to assess baseline differences between Group A and Group B.  
We checked for data distribution and logarithmic transformation was used 
for the NHPT to get normal distribution. Then the analysis of covariance 
was used to check statistically significant between group differences taking 
into account baseline values and depression (HADS) at T0. Since these two 
confounders were not statistically associated with the outcome we used a 
more parsimonious model as described in Wellek et al.26 In short the 
differences between treatment effects was assessed by a standard T-test, 
for continuous variables and Mann Whitney Test (MW) for independent 
samples using the intra-individual differences between the outcomes at 
the end of both periods (T1 and T2) as dependent variables. Similarly, we 
checked for carryover effects summing up the values measured at the end 
of both periods for each subject and comparing the two groups by means 
of another T or MW test. 
An intention to treat approach was used and drop outs were excluded from 
the analysis. All analyses were performed using Statistica software and the 
p-level was set at 0.05. 
 
 
Results  
 
Overall, 22 participants were recruited and were randomized in two 
groups: Group A and Group B (Figure 2). Two people in the Group B 
dropped out during the execution of the study: one due to a relapse and 
one for lack of motivation to participate. The baseline characteristics of the 
participants were reported in Table 1 depicting a sample with moderate to 
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severe mobility impairments. No baseline significant statistically 
differences were found between Group A and B. 
 
 
 
Table 1: Baseline clinical and demographic characteristics of the sample 
  
Total sample Group A  Group B  
P value  (n=22) (n=11) (n=11) 
Age (years) 56.7 ± 9.8 54.5 ± 7.9 55.8 ± 9.2 0.7 
Female (n, %) 14, 63% 6, 54% 8, 73%  0.37¥ 
EDSSƗ (score) 6 (2) 6.5 (0.75) 6 (1.5) 0.37 
Disease duration 
(years) 20.27 ± 10.7 18.18 ± 6.57 22.36 ± 13.7 0.23 
Dominant hand 
(R/L)  21/1 11/0 10/1 0.26¥ 
Affected hand 
(R/L) 12/10 5/6 7/4 0.19¥ 
HADS Ɨ (points) 8.5 (6) 10 (9.5) 8 (3.5) 0.30 
Note. Unless otherwise indicated, values are means ± standard deviation Ɨ 
Data are medians (Interquartile range), ¥Chi-Square test. 
EDSS: Expanded Disability Status Scale; R: right; L: left; HADS: Hospital 
Anxiety Depression Scale 
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Figure 2: Consort flow chart of the study and subject selection 
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Analysis of our primary outcome for fatigue (MFIS, Figure 3A) shows a 
statistically significant treatment effect (p=0.05) after the rehabilitation 
periods without any carry over effect (p=0.63). MFIS was lower after the 
treatment periods (T) compared to the WL periods (WL) with a median 
(IQR) MFIS between periods (WL –T) difference of 5.15 (10.67) points. 
The second primary outcome for fatigue (Rate-MV, Figure 3B) shows a 
statistically significant treatment effect (p=0.05) after the rehabilitation 
period without any carry over effect (p=0.86). Rate-MV was higher after 
the treatment periods (T) compared to the waiting list periods (WL) with a 
mean (SD) Rate-MV between periods (WL –T) difference of 0.15 (0.36) Hz. 
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Figure 3: Effect of rehabilitation on Fatigue   
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MFIS: Modified Fatigue Impact Scale; RATE- MV: Rate at maximum velocity; 
T1: assessment after 8 weeks from T0; T2: assessment after 8 weeks from 
T1; Group A: T-WL; Group B: WL-T 
 
 
 
The analysis of the first primary outcome for manual dexterity  (NHPT, 
Figure 4) shows no statistically significant treatment effect (p=0.63) after 
the rehabilitation period without any carry over effect (p=0.67) with a 
mean (SD) between periods (WL –T) difference of 3.58 (25.02) seconds. 
 
 
 
Figure 4: Effect of rehabilitation on manual dexterity    
 
 
 
NHPT: Nine Hole Peg Test; T1: assessment after 8 weeks from T0; T2: 
assessment after 8 weeks from T1; Group A: T-WL; Group B: WL-T 
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the rehabilitation period without any carry over effect (p=0.67) with a 
mean (SD) between periods (WL –T) difference of 3.58 (25.02) seconds. 
 
Finally, Figure 5 reports the results for the remaining secondary outcomes 
for fatigue and manual dexterity. No statistically between group 
differences (P>0.05) were found at the end of the T and WL periods. 
 
 
Figure 5: Effect of rehabilitation on secondary outcomes   
  
 
ARAT: Action Reaching Arm Test; HR: Heart Rate; RPE: Rate of  Perceived 
Exertion; T1: assessment after 8 weeks from T0; T2: assessment after 8 
weeks from T1; Group A: T-WL; Group B: WL-T 
 
 
Discussion 
 
The present crossover study aimed to investigate the effect of  a 
combination of aerobic and task oriented exercises on improving fatigue 
and upper limb function. Our main result is that eight weeks of exercise 
reduces subjective fatigue and increases fingers movement rate. 
Conversely, we found any improvement in upper limbs strength and 
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dexterity indicating that a more effective treatment for upper limbs 
function is needed. 
 
Several studies have investigated the effect of rehabilitation on fatigue6  
and on upper limb function15, however, no studies investigated the effects 
of combined treatments on fatigue and functional interventions. Our 
hypothesis was the use of combining treatments could be a new viable way 
to optimize well know effects of separated treatments, specifically the role 
of aerobic training as priming before functional rehabilitation. The 
comparison of our results with other published reports is difficult due to 
the lack of studies combining fatigue and task oriented exercises therefore, 
in the following paragraphs, we compare our findings with previous studies 
treating separately fatigue and upper limb function.   
 
Fatigue was present in our sample having a median MFIS baseline score of 
32 out of 84 points. At the end of the treatment we observed a median 
change score of 5 points with 70% of PwMS in the treatment phase and 
30% of PwMS in the waiting list phase that reduce fatigue after 
rehabilitation. 30% of PwMS in the treatment phase and 10% of PwMS in 
the waiting list phase have reached the cut-off score of 10 points defined 
by Kos et al. as a clinically relevant improvement.19 Other studies reporting 
the effects of rehabilitation on fatigue have shown heterogeneous results. 
Rampello et al.27 and Petajan et al.28 failed to demonstrate a change in this 
outcome. Conversely, in line with our results, Surakka et al. found that 
aerobic 6-months period comprising aerobic and strength exercises can 
reduce motor fatigue in PwMS.29 Similarly, Heine et al. found a reduced but 
not clinically relevant fatigue measured by the Check Individual Strength 
Fatigue after a rehabilitation period of 8 weeks of aerobic training with any 
impact on social participation.7 
   
The reduction in subjective fatigue was accompanied with improvement in 
the ability to sustain long motor task. Finger movement opposition rate at 
maximal velocity significantly increased (+0.17 Hz) in all patients meaning 
that the time to pass from a finger to the next one decreased from 610 to 
590 milliseconds. This result is in agreement with the previous study by 
Bonzano et al. in which movement frequency increased of 0.2 Hz after 
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rehabilitation in the same assessment.16 This improvement to perform 
higher number of movements suggests that PwMS were less deconditioned 
and more coordinated after rehabilitation, better sustaining long motor 
task at maximum velocity.  
The beneficial role of rehabilitation on reducing fatigue has been already 
known to be important on improving deconditioning, on reducing 
secondary health risks and potentially disease progression.6 Moreover a 
higher velocity in an endurance fingers tasks can imply less fatigue in PwMS 
in everyday repetitive hand activities such as writing30 or using a mobile 
phone.31 
Although not statistically significant both Rate of Perceived Exertion 
(P=0.12) and Heart Rate (P=0.22) showed a trend towards improvements. 
Half of the sample showed 10 beats per minute reduction right after the 
end of the exercise while only 15% of the sample showed similar 
improvement after the waiting list period suggesting that the change in 
general fatigue (MFIS) is associated to better cardiovascular health after 
exercise, as it has known that lower heart rate decreases risk for coronary 
artery disease and sudden death.32 
Our results are in line with previous studies.27,33, 34 Specifically, Skjerbaek 
reported that upper body exercise is tolerable for disable people with MS 
and an improvement on maximal oxygen consumption is associated with 
an improved health, increased physical activity and a lower disability level 
in MS.34  
 
With respect to our first primary outcome for manual dexterity, we found 
no changes in NHPT (Figure 4) after rehabilitation. Our results are in 
contrast with those of two previously published studies on upper limb 
rehabilitation.16,35 Carpinella et al. found  an intervention involving robot 
rehabilitation led to 13 seconds improvement in the execution of the 
NHPT35 while Bonzano et al. found both task-oriented rehabilitation and 
passive rehabilitation resulted in 4 seconds improvement.16 Lack of 
functional improvements in proximal and distal components of the upper 
limb was confirmed by results from ARAT and hand grip test measuring 
whole arm function and hand strength. These results are in line with 
previous studies16, 35, 36 showing small and not statistically significant 
improvement in ARAT and hand grip test37,38,39 after rehabilitation.  
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One of the reason for the lack of effect is that the intervention was not 
intensive enough to improve manual dexterity and function. The frequency 
and the intensity of training reported in the studies by Carpinella et al. and 
Bonzano et al. ranged from 3 to 5 days per week with a duration of the 
training sessions ranging from 45 to 60 minutes. This is supported by a 
review reporting a more intensive therapy (>15 hours) can improve 
recovery in activities of daily living in people with stroke.40,41 It is possible 
that in our study subjects received a too small amount of practice to 
improve manual dexterity, this issue should be closely considered when 
planning combined therapies because this may lead to unsatisfactory 
outcomes. A second reason is that more disabled PwMS may have been 
excessively fatigued after the aerobic training interfering with the task 
oriented training. Thus, the effects of fatigue on functional recovery should 
be carefully considered when planning tailored intervention. 
 
Study limitations 
We finally acknowledge some limitations of our study. Firstly, the small 
sample size may have affected the generalizability of the results and 
reduced the power of the study. Secondly, there was no “washout” 
between treatments, although we did not find statistically significant carry-
over effects a larger sample size may reveal bias in the analysis since 
treatment performed in one period may have a residual effect that persists 
into the subsequent period. Thirdly, patients with a higher level of fatigue 
need to be considered in further studies in order to better describe the 
impact of rehabilitation in a more fatigued population.   
 
 
Conclusion 
 
The present study reports that a combined aerobic and task oriented 
training positively reduces fatigue without improving manual dexterity and 
strength. This suggests to clinicians a beneficial role of rehabilitation on 
fatigue on upper limb but tailored and more intensive interventions are 
needed to reduce manual dexterity disorders. 
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Abstract 
 
Persons with multiple sclerosis (MS) have deficits in many aspects of 
physical and cognitive functioning that can impact on mobility and 
participation in daily life. The effect of a 4-week intensive multimodal 
treadmill training on functional mobility, balance, executive function and 
participation in persons with MS with moderate to severe disability was 
investigated.  
Methods. Thirty-eight persons with MS recovered for rehabilitation 
participated in a two-arm randomized 2:1 controlled trial. Participants in 
the experimental group received supervised dual task treadmill training 
(DT-group), 4-5 sessions per week and a control group received the same 
amount of supervised resistance training (R-group). The participants were 
assessed before and after the rehabilitation period with the 2 Minutes 
Walking Test (2MWT), static and dynamic balance measures, the Frontal 
Assessment Battery and the Short Form-12 questionnaire. A logistic 
regression was used to test the main hypothesis related to the superiority 
of the treadmill intervention based on a greater proportion of people 
making a clinically relevant gain (15% increase on 2MWT) in gait resistance 
following treatment. ANCOVA (Analysis of covariance) models adjusting for 
baseline measurement of the respective outcome variable, as well as sex, 
age and EDSS, were used to evaluate differences in efficacy for all 
variables. P was set at 0.05. 
Results. Being in the DT-group was highly predictive (OR 0.0017 (0.0017 to 
0.4154), p<0.001) of having a clinical improvement underscoring the 
efficacy of the intervention. The DT-group improved more in gait 
resistance, speed and mobility (P< 0.05). Factors to do with static and 
dynamic balance instead improved moderately in both groups following 
training while executive control and perception of health remained similar 
in both groups. 
Conclusion. A four to five week aerobic and multimodal training was more 
effective in augmenting gait resistance and mobility in moderately to 
severely affected persons with MS than resistance training.  
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Introduction 
 
Persons with multiple sclerosis (MS) can have various deficits, affecting 
many aspects of physical and cognitive functioning, frequently leading to 
low levels of physical activity in daily life which further impacts on mobility 
difficulties through deconditioning of muscles and reduced 
cardiorespiratory fitness.1,2,3 Physical inactivity, is particularly common in 
persons with MS with moderate to severe walking disability and can be due 
to many factors, such as, inability to maintain steady gait, balance deficits, 
inability to adapt to environmental demands, fatigue, as well as, cognitive 
factors.4 Physical activity, in terms of mobility, requires a balance between 
various interacting systems, locomotion, balance and the central nervous 
system (CNS) as the coordinating part, where, in particular, executive 
functions of the frontal cortex appear to be important for mobility.5 In fact, 
persons with moderate and severe MS disability often have difficulty 
walking while simultaneously doing motor or cognitive tasks leading to a 
higher risk of falls during everyday activities.6 
 
There are some indications in the literature that aerobic and strengthening 
exercises can change aspects of physical and cognitive performance of 
PwMS, with a potentially bigger benefit associated with supervised 
exercise training.7, 8, 9, 10, 11   
In particular it is suggested that high-intensity repetitive task-specific 
practice may be an effective principle when trying to promote motor 
recovery in neurological diseases.12 For elderly multimodal interventional 
strategies have been suggested to promote secure mobility by improving 
attention, dual task performance and executive functions.13 In spite of 
various studies suggesting a multimodal approach to rehabilitation to 
increase its general effect and augment physical activity, the effect of 
intense mobility rehabilitation paradigms including additive cognitive tasks 
has not been investigated in the MS population. However, there are 
preliminary indications that 20 minutes of treadmill training can 
momentarily influence cognitive aspects such as executive control.14  
Given the importance of exercise and physical activity for persons with 
multiple sclerosis that are already moderately to severely hampered by 
their locomotor ability and balance, the setting up of intense functional 
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mobility training that targets the main deficits and under close supervision, 
may be a viable way of increasing the level of physiological health and give 
a basis for the persons to start their own activity pursuit outside of the 
rehabilitation clinic. Treadmill walking has several benefits for mobility 
rehabilitation. First, it is an everyday task, walking. Second it lends itself 
well to a dual task paradigm where other aspects of mobility, such as 
equilibrium and cognitive factors can be addressed during walking. Third, 
even persons with severe walking limitations can train walking at various 
speeds when on treadmill, holding onto handrails and using safety 
harnesses that minimizes the possibility of adverse events during training. 
Further, the treadmill paradigm lends itself well to training with 
progressive task difficulty, numerous rhythmic repetitions, and importantly 
it can include an aerobic component to improve cardiorespiratory fitness. 
All of which should lead to improved submaximal exercise tolerance and 
endurance, more functional mobility and consequently increased ability to 
carry out activities of daily living. 
The aim of this study was to evaluate the safety, feasibility and preliminary 
effects of a high-intensity rehabilitative multimodal training protocol 
carried out on treadmill on walking efficacy, mobility, balance, executive 
function and health-related quality of life in a sample of persons with 
moderate to severe MS mobility compared it to a control group that 
received a strengthening program of similar intensity. 
 
 
Methods 
 
A consecutive sample of 42 People with Multiple Sclerosis (PwMS) was 
recruited from the inpatient rehabilitation service of the Don Gnocchi 
Foundation. Subjects were included in this study if they met the following 
inclusion criteria: diagnosis of multiple sclerosis according to McDonald's 
criteria,15 EDSS score ≤ 7, free from relapses and steroid treatment for at 
least 3 months) able to stand 30 seconds, able to walk at least 10 meters 
independently or with a cane, aged between 18 and 80 years, able to 
understand and follow instructions, stable neurological conditions and 
willingness to participate in the study. Subjects were excluded if they had a 
cardiac pacemaker, any heart condition that their medical doctor 
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considered risky for intense aerobic activity, any pre-existing conditions 
that affected walking function, diagnosis of depression or psychotic 
disorder. 
The study was conducted in accordance with the Declaration of Helsinki 
and was approved by the ethics committee of the Don Gnocchi 
Foundation. Subjects signed an informed consent form before the 
beginning of the study. 
 
Experimental Procedures 
The study design is a two arm randomized 2:1 controlled trial  (see study 
flow chart in Figure 1).  
 
The participants were assessed before and after the rehabilitation period 
by researchers blinded to group assignment. Primary outcome measures 
were 2 Minutes Walking Test (2MWT),16 Timed Up and Go (TUG),17 and 
Frontal Assessment Battery (FAB).18  
The secondary outcome measures were: Berg Balance Scale (BBS),19 10 
Meter Walking Test (10MWT),20 Dynamic Gait Index (DGI),21 Short Form-12 
questionnaire (SF-12).22  
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Figure 1: Flow chart of the study 
 
 
 
Randomization 
Patients were consecutively randomized to the experimental or control 
group in a 2:1 ratio, using a computerized automated algorithm. To ensure 
a concealed allocation randomization was done after determining 
eligibility. 
 
Intervention protocols 
Participants in both groups received 15- 20 treatments sessions lasting 30 
minutes 5 times per week by experienced physical therapists trained for 
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the study. All participants also followed their usual rehabilitation care 
protocols as planned. 
 
Treadmill dual task training (DT) 
Participants in the experimental group received supervised treadmill 
training, 4-5 sessions per week. The treatment protocol was aimed at 
improving participants’ resistance, walking velocity, balance and cognitive 
functions during motor and cognitive (dual) tasks. The treadmill training 
was carried out without body weight support but if needed the participants 
were attached to a safety harness. They were also allowed to use the 
handrails for balance support as needed. Exercise intensity was decided 
according to the participants scoring of the Rate of Perceived Exertion 
(RPE) on the Borg Scale (6-20)23, the training aim was to keep the 
participants in the 14-16 range of their RPE and treadmill parameters, 
speed and slope, were decided based on that. Throughout the treadmill 
session participants were monitored for heart rate. The thirty-minute 
training session consisted of three different walking bouts:  
1) An aerobic phase (0-12/30 minutes): preferred walking speed for the 
first three minutes, to be increased to taxing walking speed and an 
increased slope until 12 minutes, aiming at keeping the RPE at about 14-16 
and heart rate near 70-80% of age predicted maximum heart rate;  
2) Dual task phase (12-22/30 minutes): preferred walking speed with dual 
task activities comprising motor activities (e.g. change in velocity, walking 
without holding onto handrails, use of arms in solving motor tasks, changes 
in walking motions (long steps, walking on toes, with knee lifts), purposeful 
head rotations, walking with closed eyes) and cognitive activities (e.g. 
talking, counting, counting backward, solving memory and recalling tasks);  
3) An aerobic phase 2 (22-30/30 minutes): increase in walking speed and 
slope arriving at RPE 14-16, with the last 3 minutes at preferred speed. 
Done in this way the intervention was characterized by high intensity 
interval aerobic training. 
During the 4-week intervention, walking speed and slope was increased 
according to RPE of the participants with, however, with regard for the 
heart rate that was always kept within 80% maximum exertion. For those 
participants that could not do the whole 30 minutes initially, walking 
duration was gradually increased during the training period as tolerated, 
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with short rest periods allowed if absolutely necessary. If perceived 
exertion went to 17 or more on the Borg, the training intensity was first 
reduced slightly in order to have the participant continue at a level 14-16, 
and only if they felt they could not continue was the exercise interrupted.   
 
Resistance group (R) 
Participants in the control group were treated with Resistance exercises 
aimed at reducing improving strength in muscles involved in walking (hip 
abductors, quadriceps, plantar flexors, dorsal flexors) according to current 
guidelines from the American College of Sports Medicine.24 Given these 
recommendations three sets of 10 repetitions were performed bilaterally 
with appropriate weights for each exercise. Exercise progression was set by 
increasing the resistance of Therabands and/or weights used in the 
exercises once the participants were able to perform two sets of six 
repetitions.25  
 
Outcome measures 
The primary outcomes were gait resistance assessed with the 2 Minutes 
Walking Test (2MWT).16 The subjects were instructed to walk at their usual 
speed while the distance they covered in 2 minutes was recorded in 
meters. A change of 15% in meters walked from baseline measures to post 
intervention was considered clinically important improvement and subjects 
achieving that were termed responders while those not achieving 15% 
change were considered non-responders.  
 
All other outcomes were considered secondary. The 10 meters timed test 
was used to test gait speed and the Timed Up and Go (TUG) to assess 
functional mobility.  
In the 10 meters timed test the subjects were instructed to walk 10 meters 
at their comfortable speed, parting from a 0 meters and arriving at 10 
meters. The time taken to walk from 2 meters to 8 meters was taken.26,20 In 
the Timed Up & Go test (TUG) the subjects had to stand up from a chair 
(without armrests), walk 3m, turn back, and sit down again while being 
timed. Time taken to complete the test has been shown to be correlated to 
levels of functional mobility and with scores on the BBS as well as with 
scores on the DGI for PwMS.27, 28 
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Executive function was assessed with the Frontal Assessment Battery 
(FAB), a short cognitive and behavioral six-subtest battery used for bedside 
screening of global executive dysfunction. Total score is a maximum of 18 
with higher scores indicating better performance. The six subtests of the 
FAB explore various functions of the frontal lobes, including similarities, 
mental flexibility, motor series, sensitivity to interference, inhibitory 
control, and environmental autonomy.  The FAB has been used in studies 
of persons with MS as a measure of executive function and has been 
validated for the Italian population.29 
Static balance performance was assessed with the Berg Balance Scale 
(BBS), a 14-item scale widely used to assess balance disorders in PwMS. 
BBS provides information about patient’s balance-related abilities rating 
performance from 0 (worse) to 4 (best) on 14 items with a maximum total 
score of 56.27 Dynamic balance was assessed with the Dynamic Gait Index 
(DGI). The eight tasks of this scale include walking, walking with head turns, 
pivoting, walking over objects, walking around objects, and going upstairs. 
The maximum score is 24, indicating good dynamic balance.27  
Quality of life was assessed with the Short Form-12 questionnaire (SF-12), a 
shorter version of the commonly used Medical Outcomes Study SF-36. The 
SF12 is comprised of two domains, physical and mental and gives two 
composite scores that reflect the perceived health of the participant. Both 
scores range from 0 and 100, with a higher score indicating better health. 
These SF12-based summaries have been shown to reproduce accurately 
both scores derived from the full SF36.22  
 
Statistical analysis 
Descriptive statistics were used to detect the presence of outliers. No 
subjects were removed from the analysis. The normality of distributions 
and the homogeneity of variances were assessed by Shapiro–Wilks and 
Levene tests. Berg Balance Scale cubed scores and Timed up and go 
logarithm scores were computed to improve the normality of distribution. 
Parametric tests and non-parametric tests were used when appropriate.  
A primary statistical analysis for all outcomes was done using ANCOVA 
(Analysis of covariance) models adjusting for baseline measurement of the 
respective outcome variable, to evaluate treatment effects (measured as 
change from baseline) adjusting for baseline as well as sex, age, EDSS. 
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ANCOVAs were computed for the primary endpoint (2MWT) and for each 
of the secondary endpoints. 
Logistic regression was used to test the main hypothesis related to the 
superiority of the treadmill intervention based on a greater proportion of 
people making a clinically relevant gain in gait resistance following 
treatment. We used 15% of improvement on the 2 Minutes walking test as 
dependent variable and FAB, DGI, BBS cubed, TUG, Type of treatment as 
independent variables.  
Effect sizes expressed as Cohen's d and r were calculated for the primary 
outcomes. 
All analyses were performed using Statistica software and the p-level was 
set at 0.05. 
 
Results 
 
The flow of participants in the study is shown in Figure 1. Of the 42 
participants that started the study 38 finished the programs, 26 in the DT-
group and 12 in the R-group (Figure 1). Reasons for not completing the trial 
was anticipated dismissal from the clinic in all four cases, for reasons not 
related to the study protocol. On average, subjects in both groups 
completed 18 sessions. There were no adverse events reported during or 
following either treatment except muscle and general fatigue that was 
resolved in a couple of hours after the session. After the first couple of 
sessions some participants complained of muscle soreness and increased 
stiffness but once ascertained that they were natural consequences of 
beginning a new intensive motor activity they continued the training 
without further complaints.  
Baseline characteristics of the two groups are shown in Table 1. There were 
no differences between groups in any demographic, disability or ability 
parameter at baseline.  
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Table 1: Demographic and clinical features of experimental and control 
groups. 
 
 
EDSS: Expanded Disability Status Scale; BBS: Berg Balance Scale, TUG: 
Timed Up and Go; 2MWT: 2 minutes walking test; DGI: Dynamic Gait Index; 
SF12_Mental: Short Form-12_ Mental Health Questionnaire; 
SF12_Physical: Short Form-12_ Physical Health Questionnaire; PP: Primary 
Progressive; SP: Secondary Progressive; RR: Relapsing Remitting 
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Primary outcome  
Number of persons improved in gait resistance versus not improved. 
The baseline value of the primary outcome, gait resistance measured by 
the 2MWT did not differ between groups at baseline. Following 
intervention 19 out of 26 persons (73%) in the DT-group improved clinically 
in gait resistance (>15%) whereas 2 out of 12 persons (16,7%) improved in 
the R-Group. The DT-group improved significantly more (d=1.31, p<0.001) 
than the R-group in gait resistance, with a 29.9 meters (33.3%) increase in 
meters walked during the 2MWT while the resistance group did not change 
(0.2 meters, change of 0.3%). The mean difference in change between the 
two groups was 28.3 ± 7.5 and was statistically significant (p<0.001) (Table 
2).  
 
Table 2: Outcomes of the ANCOVA in the DT-group and R-group post 
intervention and effect sizes with confidence intervals. 
 
 
Abbreviations: n: number; SD: standard deviation; DT: Treadmill Dual Task 
Group; R: Resistance Group; 2MWT: Two-minutes walking test; BBS: Berg 
Balance Scale; TUG: Timed up &Go; DGI: Dynamic Gait Index; FAB: Frontal 
Assessment Battery; SF12_Mental: Short Form-12_ Mental Health 
Questionnaire; SF12_Physical: Short Form-12_ Physical Health 
Questionnaire. * Adjusted for pretreatment score (T0) by analysis of 
covariance; Ɨ These variables did not meet assumptions of data normality 
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and/or homogeneity of variances. In this cases, statistical tests and Cohen 
d computation were performed on transformed data. Reported between-
group differences were estimated from back-transformed results to 
facilitate interpretation; ʎ Higher scores indicate better performance; Ϩ 
P<.05 (DT vs R, contrast analysis using independent sample t test); ¥ Lower 
scores indicate better performance 
 
 
A logistic regression including type of treatment (DT-group or R-Group), 
age, MS type, EDSS and disease duration was run with predicted outcomes 
improved versus not-improved (see table 3). The model was significant 
(p<0.01) for type of treatment Persons in the DT-group has 0,0017 OR 
(0.0017 to 0.4154) more to be improved following treadmill dual task 
treatment; while age, MS type, EDSS and disease duration were not 
significant predictors of improved persons in the model.  
 
 
 
Table 3: Logistic regression analysis between demographic, clinical 
variables, type of treatment and number of improved patients at 2MWT 
(∆2MWTpost-pre ≥15%) 
  Const.B0 AGE MS 
type 
EDSS Disease 
duration 
Type of 
treatment 
Estimate -60.49 -0.10 0.65 0.19 0.03 -3.62 
Standard 
Error 
74.92 0.06 0.76 0.54 0.07 1.34 
t(30) -0.81 -1.60 0.86 0.36 0.39 -2.70 
p-level 0.43 0.12 0.40 0.72 0.70 0.01 
Logistic regression (logit) N of 0 (improved): 29 ; N of 1 (not improved): 9 
Final loss: 15.58; Chi²(5)=17.74; p=.003. Abbreviations: Const.B0: constant 
of logistic regression; MS type: type of Multiple Sclerosis; EDSS: Expanded 
Disability Status Scale. 
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Secondary outcome 
 
Results following intervention for all outcome measures are shown in Table 
2. A significant difference was found between groups in improvement in 
gait velocity and mobility. 
The DT-Group improved significantly more on the TUG (p<0.01) than the R-
group, with a reduced time to complete the test of 2.9 sec (19.1% 
improvement) versus an increased time taken by the R-group of 2.9 
seconds (11% worsening). The DT-group also increased their speed 
significantly more than the R-group (P=0.01), with a 0.2 m/s increase 
(21.4%) in gait velocity from baseline versus no change in the R-group, 0.02 
m/s (2.5%).  
There were no other significant differences between groups in 
improvement at post. Both groups improved their static balance, the DTT-
group by 4 points on the BBS (9.3%) and the R-group by 2.9 points (6.6%), 
as well as, dynamic balance with the DT- group improving by 2.4 points on 
the DGI (15.2%) and the R-group by 1.7 points (10.4%).  
Regarding executive function measured with the FAB, there were no 
differences between groups at baseline nor following intervention. The DT 
group with a baseline of mean 14.8 points out of 18 possible increased 1.7 
points (11%), while the R-Group with a baseline of 15.9 points increased 
0.4 points (2.5%).  There was a strong ceiling effect on the FAB. Only 10 out 
of the 26 persons in the DT group had an abnormal score on the FAB (<15) 
at baseline and 4 out of 12 in the R-group. Following intervention, the 
persons with abnormal scores in the DT-Group had augmented their scores 
on the average by 4.2 points and in the R-Group by 2.5 points.  
Perception of health was moderately low at baseline in both groups at 39.3 
and 42.0 respectively in the DTT-group and the R-group on the SF-
12_Mental and there was no difference between groups following 
intervention. The same was true for SF-12-Physical, the groups scored 33.8 
and 37.4 respectively at baseline and there was no significant difference 
between groups following treatment. 
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Discussion 
 
The present study examined the response of moderately to severely 
affected PwMS to an intensive multimodal training on treadmill and 
compared it to a control group that received a strengthening program of 
similar intensity. More people in the treadmill group improved their gait 
resistance than in the strength training group and as a whole the group 
improved much more in gait resistance, speed and mobility. Factors to do 
with static and dynamic balance instead improved moderately in both 
groups while executive control and perception of health remained similar 
in both groups following training.  
 
Gait resistance  
Nineteen persons out of the 26 persons in the DT-group improved clinically 
(>15% from baseline) on the primary outcome, gait resistance, while only 
two of the 12 persons in the C-group improved clinically. The logistic 
regression analysis indicated that being in the DT-group was highly 
predictive of having a clinical improvement after intervention.  
Post intervention the DT-group had improved on the 2 Minute walking test 
in a statistically and clinically significant way by increasing of 33,3% from 
baseline (30 meters), while there were no changes in the control group. 
The improvement reached was well above the 20-25% improvement 
reported by most studies reporting on persons with MS doing gait training 
on the treadmill and overground30, 31 and well above the MCD of 9.6 
meters established for the 2MWT by Feys et al.32 A study carried out by 
Kalron and colleagues on persons with MS of similar disability severity that 
did training on the treadmill saw a mean change of 20 meters in gait 
resistance.31 Some differences in the training protocol may explain the 
bigger efficacy of the treadmill training in the present study.  
First of all, the intensity of our training is higher in terms of workload 
during a week compared to a previous study by Braendvik et al.in which 
subjects performed training 3 times per week for 8 weeks for a total of 24 
sessions of treadmill or strength training.33 In contrast, Mostert and 
Kesselring reported training of similar intensity to the present study (5*30 
minutes per week) with benefits for aerobic fitness, fatigue, and an 
increase in level of physical activity and perception of health.34 Our training 
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intensity was similar to the intensity used in the study by Mostert and 
Kesselring et al. confirming that higher disabled PwMS can benefit from a 
high training intensity resulting in improved mobility.    
 
 Moreover, with respect to the content of the sessions on treadmill, 
interval training and variability in speed and slope were conducted during 
the sessions. Although the type of treatments was not strictly tied to the 
activity during gait but rather to the cardiovascular parameters34, 35 with 
bigger improvement in cardiovascular parameters in a group that did 
interval training compared to a group that did the same intensity of aerobic 
exercise but with continuous training.36  
 
Gait velocity and TUG 
Our results are supported by results from the literature indicating that 
task-specific training by treadmill walking is a favorable approach to 
improve mobility in persons with moderate to severe MS as compared with 
strength training.37, 33  
The increase in gait resistance of the DT group was reflected in higher gait 
speed (+0.2 m/s) and an improvement in mobility with a reduction of 2.8 
sec on the TUG. Similarly, Kalron observed an overall reduction of 2,3 secs 
on the 10-meter walking test and 2,4 sec on the TUG in the severe group.37 
The present results thus strengthen proof from the existent literature 
adding to evidence based knowledge for the decision of optimal treatment 
approaches to improve mobility in PwMS. 
 
 
Balance 
The sample was moderately affected in their balance with scores at 
baseline that were on the verge of the cut off for fall risk established by 
Cattaneo et al. for PwMS.27 Both groups improved in static balance, by  four 
points (9%) and approximately three points (7%) on the BBS respectively 
for the DT-group and the R-group Specifically, an improvement near or 
over the MCID of three points established by Gervasoni et al.38 showed a 
small but clinically important overall effectiveness of both rehabilitation 
approaches. Results were similar for dynamic balance, there was an 
increase of 2,3 (15%) and 1,6 points (10%) on the DGI for the treadmill and 
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the resistance group respectively indicating that treadmill training was 
minimally effective in improving dynamic balance since SEM for the DGI 
has been established at 2 points of the scale and MDC at 4,2.27 Although 
the treadmill training  included parameters such as walking without hand 
support or turning head and walking with closed eyes during the treadmill 
training only about 12-15 minutes of the treadmill time was dedicated to 
these dual task activities, including both cognitive exercises and motor 
activities. It is possible that this was not enough time in balance training to 
have a bigger impact on balance deficits. Our hypothesis is line with a 
recent review by Gunn et al. that reported that a high volume of 
challenging balance exercise program may be needed in order to have 
greater benefit on balance and therefore potentially in reduction of falls.39  
 
Executive function 
Regarding executive function measured by the FAB, there were no 
significant changes after intervention. Our results are in contrast with 
Sangelaji et al. demonstrating that 24 sessions of combined aerobic and 
balance training resulted in a significant increase in cognition measured by 
Digit Symbol Modality Test (DSMT).40 Moreover, a review by Kalron 
reported that persons with MS participating in active intervention or 
exercise groups improved more in cognitive measures than a not active 
controls, implying an impact of exercise on cognition.41 Given our sample in 
which baseline values are near to the maximum score of the FAB scale, one 
explanation could be that FAB is not sensitive enough to depict changes 
after the rehabilitation period due to tool ceiling effect.  
 
Perceived health 
Regarding quality of life in terms of health perception, there were no 
significant changes neither in physical nor the mental domain in both our 
groups. Our results didn’t support the results showed by Motl et al. 
reporting a significant effect for aerobic exercise, but not for non- aerobic 
exercise (e.g., yoga and resistance training) on improving quality of life.42 
One explanation could be that we treated both inpatient groups and they 
cannot experience real life at home during the period of recovery in the 
hospital, thus it is possible that they had difficulty to perceive 
improvements outside of their daily context. 
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General conclusions and limitations 
 
In the current study the emphasis was on achieving speed and stressing the 
aerobic system during two thirds of the treadmill time. Our main result 
showed a significant improvement in the treadmill training group in all the 
parameters associated with gait resistance, speed and mobility compared 
to a control group that did strengthening exercises at a similar exercise 
intensity. Balance and cognitive dual tasking exercises were incorporated 
into the walking time for about one third of the treadmill time, however, 
for the rest of the time the subjects were allowed to hold onto the side 
rails in order to achieve faster walking speeds. It is possible that with more 
time spent in multimodal training the balance component of the training 
would have been even more effective. Given the importance of 
investigating methods to improve cardiovascular health and increase 
physical activity in persons with MS, further studies are needed. 
We acknowledge some limitations of the study. Firstly, while the short-
term effects of our exercise training study are encouraging, no follow up 
measures were performed. Secondly, no assessment measuring fatigue 
was done. Thirdly, aerobic multimodal training was compared to resistance 
training with many of the outcomes being more specific to the aerobic 
multimodal training. The possibility that resistance training was more 
effective in improving non-aerobic parameters (beyond balance, fatigue, 
QoL that should be common to all interventions) such as, muscle strength 
cannot be excluded. 
 
Conclusion 
 
A four to five-week aerobic multimodal training was much more effective 
in augmenting gait resistance and mobility in moderately to severely 
affected PwMS than resistance training while both groups had modest 
benefits from training on balance and quality of life. This underscores the 
possibility of improving mobility and cardiovascular health also in persons 
with MS with relatively high disability levels with a potential impact on 
their physical activity and daily life participation. 
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EFFECTS OF FUNCTIONAL ELECTRICAL STIMULATION ON 
REDUCING FALLS AND IMPROVING GAIT PARAMETERS IN 
MULTIPLE SCLEROSIS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 81 
 
Abstract 
Background. Loss of neuromuscular control of the ankle joint is a common 
impairment in neurological conditions, leading to abnormal gait and a 
higher risk of falling. However, limited information is available on the 
effectiveness of Functional Electrical Stimulation (FES) on reducing falls, 
and no studies have investigated its usefulness in improving lower limbs 
kinematics related to foot clearance and energy recovery. 
Setting. Clinical setting. 
Study Design. Longitudinal study. 
Participants. Fourteen people with multiple sclerosis (mean age ± standard 
deviation 50.93 ± 8.72 years).  
Methods. The number of falls was assessed at baseline and after 8 weeks, 
and a clinical assessment was assessed at the baseline, 4-week and 8-week 
time points. A subsample of the 14 subjects comprised of 5 people with 
multiple sclerosis performed a gait analysis assessment at baseline and 
after 4-weeks. After receiving the equipment and the training schedule, 
subjects performed daily home walking training using FES for 8 weeks. 
Main Outcome Measurements. The main outcomes were 1) the number of 
falls, 2) foot clearance, and 3) energy recovery. 
Results. A reduction in the number of falls was observed from baseline to 
the 8-week assessment, p=.04.  Foot clearance increased (+ 7.39 mm, 
p=.03) between the baseline without FES and at 4 weeks with FES (total 
effect). No statistically significant differences were found in energy 
recovery between baseline and 4 weeks. 
Conclusions.  The use of FES had an impact on gait, specifically reducing the 
number of falls and improving walking. A specific effect at the ankle joint 
was observed, increasing foot clearance during the swing phase of gait. 
This effect was not accompanied with a reduction in the energetic 
expenditure during walking in subjects with multiple sclerosis. 
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Introduction 
 
Loss of neuromuscular control of the ankle joint is a common impairment 
in neurological conditions, such as multiple sclerosis1, stroke2 and traumatic 
brain injury.3 
Damage to the motor cortex or corticospinal tract and variability in the 
area of lesion and the degree of pathology often result in a significant 
persistent distal weakness. Patients with this pattern are often unable to 
actively dorsiflex the foot during the swing phase of gait.4 The deficit of 
motor control in the ankle joint, typically because of a combination of 
weakness of the agonist ankle dorsiflexors muscles and spasticity of the 
antagonist plantarflexor muscles,5 results in slower and abnormal gait, and 
leads to gait compensation strategies consisting of hip hitching, 
circumduction and toe catch.6 This inefficient gait pattern also contributes 
to slow walking, high energy expenditure, reduced foot clearance and 
muscles7 that may result in a higher chance of stumbling and falling.8  
Loss of neuromuscolar control of the ankle joint during the swing phase is 
traditionally treated by an ankle foot orthosis (AFO), but Functional 
Electrical Stimulation (FES) has been developed as an alternative 
treatment.9  Previous studies using FES have demonstrated that the 
common peroneal nerve stimulates the tibialis anterior muscle to produce 
foot dorsiflexion during the swing phase of the gait cycle and reduces foot 
drop by facilitating increased voluntary muscle activity, and that this 
improves the quality and symmetry of gait.5 In addition, others studies 
investigated the effect of FES showing improved walking speed and energy 
in subjects with multiple sclerosis.10,11 
 However, limited information is available on the effects of this device on 
reducing falls and on the kinematics changes in lower limbs. No studies 
have investigated an important kinematic parameter, such as foot 
clearance (defined as the minimum distance between the foot and the 
ground during the swing phase of the gait 12), which has been found to be a 
common cause of falling in multiple sclerosis patients.5,613 Moreover, to 
the best of our knowledge, no studies have investigated other parameters, 
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such as energy recovery (defined as the exchange between potential and 
kinetic energy in the movement of the centre of mass during walking). 
Energy recovery is associated with changes in gait speed observed with FES 
treatment.14  
 
Therefore, the aims of this study are to assess 1) the effectiveness of FES 
on reducing falls, 2) the effectiveness of FES on improving foot clearance 
and lower limbs kinematics, and 3) the effectiveness of FES on promoting 
energy recovery. 
 
 
Methods 
 
Participants 
A consecutive sample of 14 people with multiple sclerosis was recruited. 
The subjects were recruited from the outpatient/inpatient rehabilitation 
service of the Don Gnocchi Foundation.  
Subjects were included in this study if they met the following inclusion 
criteria: diagnosis of or multiple sclerosis with at least 90 degrees of 
passive dorsi-flexion at the ankle and the ability to walk at least 10 m 
independently or with a cane, a Mini Mental State Examination [15] score 
greater than 24, aged between 18 to 80 years and willingness to participate 
in the study. 
Subjects were excluded if they had a cardiac pacemaker, skin lesion at the 
site of the stimulation electrodes, Modified Ashworth Scale16 score of the 
calf muscles that was more than 4, severe weight-bearing pain, any pre-
existing conditions affecting walking function, diagnosis of depression or 
psychotic disorder, inability to elicit significant muscular contraction of 
tibialis anterior at baseline.  
The study was conducted in accordance to the declaration of Helsinki and 
was approved by the ethics committee of Don Gnocchi Foundation.  
Subjects signed an informed consent form before the beginning of the 
study.  
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Primary outcomes: 
According to the aims of this study, the primary outcome measures were 
number of falls, foot clearance and energy recovery factor. 
The number of falls during the study were monitored prospectively for 8 
weeks by the use of a diary. Participants were also interviewed to recall the 
number of falls in the 2 months before their study participation. The fall 
was defined as “an episode of unintentionally coming to rest on the ground 
or lower surface that was not the result of dizziness, fainting, sustaining a 
violent blow, loss of consciousness or other overwhelming external 
factors”.17 
Foot clearance, lower limbs kinematics and energy recovery factor were 
assessed using instrumented gait analysis on the subsample of 5 people 
with multiple sclerosis. Subjects were recorded while walking in the 
laboratory using comfortable shoes at their own comfortable speed 
without FES at baseline. The test was repeated 4 weeks later in the same 
condition with and without FES. SMART motion analysis system6 and LAMB 
protocol [18] were used to assess the three dimensional kinematics of the 
subject’s lower limbs. Foot clearance, defined as the distance between the 
foot and the ground at minimum clearance during the swing phase, was 
measured [8]. To understand the contribution of each joint in determining 
foot clearance, hip elevation, hip flexion, knee flexion and ankle 
dorsiflexion were calculated at the minimum clearance value.19 Step length 
and ankle dorsiflexion at initial contact were also recorded. 
Energy recovery factor was computed as described by Cavagna14, and it is 
defined as the percentage of mechanical energy recovered via exchange 
between kinetic and potential energy in the centre of mass movement.  
 
Energy Recovery Factor = (Wne – Wext)/ Wne*100,  
 
Wne is the maximum work one should do without energy shift, and Wext is 
the work actually performed. A 100% recovery means a perfect transfer 
                                                          
6
 BTS S.p.A. 
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between kinetic and potential energy, healthy subjects have an energy 
recovery of 65% while walking at 4 km/h.14   
  
Clinical assessment 
 
Gait measures were assessed in terms of walking speed by the ten-meter 
walking test (10-MWT) and walking endurance by the six-minute walk test 
(6-MWT). 10-MWT: The subjects were instructed to walk for 10 meters at 
their comfortable speed with and without FES. Gait speed reflects aspects 
of walking abilities and is commonly used to measure mobility in people 
with neurological dysfunction.20,21 6-MWT: The subjects were instructed to 
walk at their usual speed for 6 minutes. The distance they covered in 6 
minutes was recorded. This is an endurance measure in people with 
stroke22 and in people with multiple sclerosis.23  For 10-MWT and 6-MWT, 
subjects walked twice with and without FES. For every subject, the trials 
were conducted in a randomized order with 10 minutes’ rest between the 
two tests. Manual Muscle Test (MMT)24 was used to assess the ankle 
dorsiflexors strength, with a score ranging from 0 to 5 where 0=no muscle 
recruitment; and 5=full muscle strength against external resistance. 
Fugl-Meyer (lower limbs) (FM)25 was used to assess motor function with a 
score ranging from 0 to 100 where 100 means best performance, sensory 
function, balance, joint range of motion, joint pain and each item is graded 
on a 3-point ordinal scale (0 = cannot perform; 1 = performs partially; 2 = 
performs fully) with a maximum score of 100. 
 
 
Experimental procedures  
 
The study protocol is shown in Figure 1.  
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Figure 1:Flow chart of the study 
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Visit 1: Baseline  
The participants were assessed for the following outcomes: Number of 
falls, instrumented gait analysis and clinical assessment. Furthermore, 
subjects received the equipment, the training schedule and were shown 
how to use the device. A daily diary was used to record the training time 
and any adverse events.  
 
Visit 2: 4-week 
After 4 weeks, subjects returned to the hospital and repeated the 
instrumented gait analysis and clinical measures.  
 
Visit 3: 8-week 
Finally, at 8 weeks, subjects brought back their falls diary and repeated all 
clinical measures.  
 
Walking Training Protocol 
 
Subjects were asked to walk daily using Functional Electrical Stimulation 
daily for a total of 8 weeks. Training time was increased according to the 
following schedule: the first week, the subjects wore the device for 15 
minutes to 1 hour according to individual tolerance, in the second week, 
for 30 minutes to 4 hours and in the third week, subjects were asked to 
wear the device for as long as possible. From the third week until the 
eighth week, participants maintained the training schedule achieved in 
week three. The device used in the study was the Ness L300 Functional 
Electrical Stimulator. This device delivers electrical pulses to the common 
peroneal nerve throughout the swing phase of gait leading to ankle 
dorsiﬂexion. An expert clinician set the device intensity and pulse 
frequency to obtain an optimal dorsiflexion response26 
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Statistical analysis 
 
Results were presented as the mean ± standard deviation for normally 
distributed variables and median ± interquartile range for non-normally 
distributed variables. The Wilcoxon signed rank test was used to analyze a 
statistically significant difference in the number of falls between baseline 
and 8-weeks. For the foot clearance, lower limbs kinematics and energy 
recovery factor, the comparisons between performances with FES and 
without FES were conducted on data from the treated leg. Data were 
tested for normality and were analyzed with repeated measures ANOVA. 
Statistically significant differences between groups were assessed with the 
Newman–Keuls post hoc test. The total effect (baseline without FES vs 4-
week with FES), walking training effect (baseline without FES vs 4-week 
without FES) and 4-week without FES vs 4-week without FES were 
calculated.  
For clinical assessment, non-parametric Friedman ANOVA and Friedman 
ANOVA post-hoc tests were used. Similar to instrumented gait analysis, we 
calculated the total effect, walking training effect and orthotic effect. We 
used a per protocol analysis and an intention-to-treat analysis on clinical 
measures. Since no differences were observed between the per protocol 
and intention-to-treat analysis, we reported results pertaining to the 
intention-to-treat analysis. In the case of missing data, a last observation 
carried forward procedure has been used. The level of statistical 
significance test was set at P<.05. 
  
 
Results 
 
Fourteen subjects were included in the study. Patient characteristics are 
shown in Table 1.  A subgroup of 5 people performed instrumented gait 
analysis, and the characteristics of this subsample are also presented in 
Table 1.  
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Table 1: Demographic and clinical features of the total sample and 
subsample. Mean and standard deviation (SD) or number (%) are reported. 
 
 
 
 
 
Effectiveness of FES on the primary outcomes  
 
7 falls were recorded at baseline and 1 fall were recorded after eight weeks 
of walking training showing a statistically significant reduction in the 
number of falls compared to the baseline, p = .04. Number of fallers (at 
least one fall) and frequent fallers (more than one fall) were reported in 
Figure 2. 
 
 
 People with multiple 
sclerosis (n=14) 
Subsample 
(n=5) 
Female N(%) 7 (50%) 3 (30%) 
Age Years 50.93 (8.72) 56.87 (14.01) 
Time since Onset Years 17.51 (9.41) 12.83 (12.60) 
Affected side (right) N (%) 12 (86%) 3 (60%) 
Assistive device N (%) 6 (43%) 3 (60%) 
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Figure 2: Hystograms showing number of Fallers at baseline and 8-week 
 
 
There was an overall statistically significant improvement in foot clearance 
between baseline and 4-weeks. Post hoc analysis showed a significant total 
effect (+7.39 mm, p =.03). On the other hand, no statistically significant 
differences were observed for the walking training effect and the orthotic 
effect. An overall statistically significant change was observed in ankle 
dorsiflexion at the initial contact (p=.05). No changes were observed in 
ankle dorsiflexion at clearance (Table 2). 
Finally, no changes were observed in the energy recovery factor between 
baseline and the 4-week assessment (Table 2). 
 
 
 
 
 
 
 
 
5 
1 
BASELINE 8-WEEK 
Number of Fallers 
35% 
7% 
 91 
 
Table 2:Instrumented gait analysis: foot clearance, lower limbs kinematic 
and energy recovery factor. Means (Standard Deviations) are reported.  
  
BASELINE 
 
Without 
FES 
 
 
4-WEEK 
 
Without FES 
 
4-WEEK 
 
With FES 
Overall 
p-level 
Post-hoc total 
effect 
(Baseline 
without FES 
vs 4-week 
with FES) 
 
Clearance (mm) 
 
15.41 
(6.38) 
 
22.8 (12.53) 
 
17.82 
(7.19) 
 
p=.04 
 
7.39 (7.8) 
p=.03 
 
Ankle dorsiflexion at 
the initial contact 
(degrees)* 
 
-37.66 
(9.46) 
 
-35.29 (6.32) 
 
-41.17 
(8.64) 
 
p=.05 
 
2.38 (6.02) 
p=.05 
 
Energy Recovery 
factor (%) 
 
40 (0.5) 
 
43 (1) 
 
42 (1) 
 
p=.59 
 
-2 
Overall p-value: ANOVA’s p values across means. * higher values indicate 
increase of ankle dorsiflexion 
 
 
Effectiveness of FES on clinical assessment 
 
There was a significant overall effect of FES on 10-MWT (p<.05 , Figure 3). 
Post hoc comparisons showed differences in the total effect between 
baseline (without FES) and the 4-week assessment (with FES) and between 
baseline and the 8-week assessment (with FES). Subjects completed the 
test 1.63s (4-week) and 5.12s (8-week) faster than at baseline 
corresponding to a change in gait velocity from 0.48 m/sec (baseline) to 
0.63 m/sec (4-week) and 0.64 m/sec (8-week), respectively. Post hoc 
comparisons also showed a walking training effect between baseline 
(without FES) and the 8-week assessment (without FES). 
There was a significant overall effect of FES on 6-MWT (p<.05, Figure 3). 
Post hoc comparisons showed differences in the total effect between 
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baseline and the 4-week assessment and between baseline and the 8-week 
assessment where subjects walked 59 meters (4-week) and 66 meters (8-
week) more than at baseline. Post hoc analysis also showed a walking 
training effect between baseline and 8-week assessment. At 8-weeks, 
subjects walked 41 meters more than at baseline.  
Finally, medians and interquartile ranges of the Manual Muscle Test, Fugl-
Meyer and Stroke Impact Scale at baseline, at 4 weeks and at 8 weeks were 
reported in Table 3, showing a statistically significant improvement 
between assessments. 
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Figure 3: Total effect and walking training effect of 10MWT and 6MWT at 
baseline, 4-week, 8-week 
 
 
 
10MWT: Ten meters walking test; 6MWT: Six minutes walking test; With 
FES: device switched on; Without FES: device switched off; 4-week: 
assessment after 4 weeks; 8-week: assessment after 8 weeks 
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Table 3: Medians and Interquartile range of clinical outcomes at baseline, 
at 4-week and at 8-week. 
MMT: Manual Muscle Test; FM: Fugl-Meyer; SIS Mob: Stroke Impact Scale 
Mobility; overall p-value: Friedman ANOVA’s p values across medians. 
 
 
Means and standard deviations of the kinematic parameters were reported 
in the supplementary table (Table S1). Hip and knee motion at clearance, 
step length, gait speed and cadence did not show changes between 
baseline and 4-weeks with and without FES. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BASELINE 
Median (IRQ) 
4-WEEK 
Median (IRQ) 
8-WEEK 
Median (IRQ) 
Overall p-value 
MMT 1 (1) 2 (2) 2 (1) .02 
FM 76.00 (19) 83.00 (18.00) 82.00 (15.00) < .001 
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Table S1: Kinematic analysis of hip, knee motion, step width, step length, 
gait speed, cadence. Means (Standard Deviations) are reported.  
  
Baseline 
 
Without FES 
 
 
4-week 
 
Without FES 
 
4-week 
 
With FES 
Overall 
p-level 
Total effect 
(Baseline 
without FES 
vs 4-week 
with FES) 
 
Knee flexion at 
clearance (degrees) 
 
22.78 (10.18) 
 
27.57 (11) 
 
27.12 (10.92) 
 
p=.07 
 
4.79 (4.54) 
 
 
Hip flexion at 
clearance (degrees) 
 
24.08 (2.65) 
 
24 (7.14) 
 
25.43 (5.78) 
 
p=.78 
 
 
-0.08 (6.55) 
 
 
Hip elevation at 
clearance (degrees) 
 
-2.69 (2.95) 
 
-1.79 (0.93) 
 
-2.72 (1.78) 
 
p=.71 
 
0.90 (3.48) 
 
 
Step length (%body 
height) 
 
52.34 (3.26) 
 
50.75 (4.63) 
 
51.14 (3.95) 
 
p=.07 
 
1.58 (2.74) 
 
 
Gait speed (%body 
height/sec) 
 
 
29.87 (7.92) 
 
31.13 (11.31) 
 
29.44 (10.09) 
 
p=.65 
 
1.26 (4.42) 
 
Cadence (steps/min) 
 
36.83 (3.9) 
 
37.18 (6.43) 
 
 
36.84 (4.49) 
 
p=.39 
 
0.35 (2.62) 
Overall p-value: ANOVA’s p values across means. 
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Discussion 
 
The results of this study demonstrate that in group of patients with 
multiple sclerosis,  a walking training protocol with FES for 8 weeks 
benefited individuals with neurological disorders who had unstable ankle 
joints, thereby reducing the number of falls and improving walking 
kinematic parameters without any improvement in energy recovery. 
The first result of this study is that the use of FES reduced the number of 
falls even if subjects were asked to walk for longer than before and to 
increase their daily activities. This is an important issue, which show high 
prevalence of falls leading to fractures and diminished quality of life.27,28 To 
understand whether this reduction in number of falls was related to 
changes in the gait pattern, we examined the effects of FES on foot 
clearance and in lower limbs kinetic variables.29,30 We found an 
improvement in clearance after 4 weeks training, providing evidence to 
support the link between foot clearance and trips and slips due to lack of 
control of the ankle muscles31 leading to an abnormal position of the foot 
and its premature contact with the ground.32  
The second result of this study is that the improvement in foot clearance 
was due to increased ankle dorsiflexion with a small contribution at knee 
and hip level. This finding suggests that the FES had a specific effect at the 
ankle and that the increase of clearance was not due to compensatory 
movements at proximal joints. Increased dorsiflexion was also evident at 
initial contact, improving the ability to place the foot in the right position 
with respect to the ground avoiding premature forefoot contact and 
promoting foot evertion during mid swing. Our results are in agreement 
with the study of Van der Linden et al. in which subjects gained 2.6° at the 
ankle joint during gait with FES.33 
The third result is that the use of FES did not improve energy recovery, 
resulting in a less efficient exchange between kinetic and potential energy. 
This finding could be partially due to the small differences in energy 
recovery between our sample and healthy subjects walking slowly34 
suggesting that the basic energy recovery mechanism was already partially 
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exploited. It is also possible that even with FES, subjects did not properly 
place the foot in the right position to use the heel as a pivot at foot strike, 
conserving the momentum generated at push-off to propel the centre of 
mass forward and up favoring the exchange between kinetic and potential 
energy at heel strike.35 In addition, it has been suggested that FES of the 
dorsiflexors alone does not address other critical gait deficits, such as 
reduced push-off forces and ankle plantar flexor moment during terminal 
stance. Recent work has shown that delivering FES to ankle dorsi and 
plantarflexors increases the production of external mechanical energy 
improving energy recovery of stroke patients.36 
Finally, reduction in falls and improvement in ankle dorsiflexion were 
associated with changes in endurance and gait speed, reduction of 
impairments and increased independence in activity of daily living. 
 Previous studies reported improvements in walking endurance for periods 
ranging from 6 to 30 weeks.8  Our data suggest that a period of 8 weeks is 
optimal to achieve a clinically meaningful effect on walking endurance. 
After the training, subjects walked almost 40 m farther than at baseline on 
6-MWT. According to Baert et al., an improvement greater than 21.6 m can 
be considered clinically relevant for people with multiple sclerosis.37  
Improvement in walking endurance was also accompanied by greater 
walking speed at 10-MWT than the baseline without reaching the 
threshold (>1.04 m/s) to pass from unlimited household walker to most-
limited community walker.38 After training, subjects improved walking 
endurance even without the device. These results are consistent with the 
findings reported by Dunning et al. 8 and Robbins et al.,39 suggesting the 
walking protocol increased subjects’ resources independently from the use 
of the device. Interestingly, we did not observe statistically significant 
changes when comparing subjects’ performance with and without FES at 
baseline (orthotic effect). On the other hand, significant improvements 
were observed at 4 and 8 weeks. This suggests that a treatment protocol 
should always be performed before the prescription of the device.  
After training motor impairments decreased, the muscle strength of the 
tibialis anterior was increased, as revealed by the Manual Muscle Test, and 
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ankle attitude and movements of the lower limbs improved, as suggested 
by changes in the Fugl-Meyer scale. These results are consistent with the 
findings reported in a review in people with stroke by Glinsky et al., 
indicating that electrical stimulation can be effective for increasing 
voluntary muscle strength.40 
There are several limitations to this study that need to be addressed. 
Firstly, the study sample is small and without a control group. Studies on a 
larger sample with an instrumented and clinical assessment are warranted 
to apply these results to a larger population. Secondly, an instrumented 
assessment should be added at 8 weeks to understand whether the same 
results were maintained during the entire protocol. Thirdly, a longer 
follow-up period could be useful to evaluate long-lasting effects of FES and 
adherence.   
 
Conclusions 
 
The use of FES had an impact on gait, reducing the number of falls and 
improving walking. A specific effect at the ankle joint was observed, 
increasing foot clearance during the swing phase of gait. This effect was 
not accompanied by a reduction in the energetic expenditure during 
walking in subjects with multiple sclerosis. 
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Conclusions 
 
This doctoral work provides insights on a more comprehensive 
evaluation of fatigue and motor functional impairments and mobility 
disorders. It provides results based on a specific controlled physiological 
and clinical rehabilitation assessment and what effect the rehabilitation 
has on daily activities.  
Furthermore, the present work provides information helping  clinicians 
to better tailor rehabilitation strategies aimed to reduce fatigue and 
improve motor function.  
 
Our findings can be outlined in the following central messages: 
 
We set up a cross-sectional study and we integrated basal and 
functional measures of cardiac autonomic tone to evaluate the presence 
of subclinical autonomic dysfunction in PwMS and evaluate how this 
may have an impact on cardiovascular responses to everyday life 
activities, as light exercise and postural challenges. We found that 
parasympathetic basal tone and post-exercise reactivation appear to be 
impaired in PwMS, but heart rate modulation during postural challenge 
and exercise seems to be preserved. Furthermore, subclinical autonomic 
dysfunction doesn’t seem to affect perceived fatigue. 
 
Given the safety of exercise and the lack of cardiac autonomic 
dysfunction during exercise, we designed a crossover study which 
combines aerobic training and task oriented exercises aimed to reduce 
fatigue and improve upper limb impairments and function. We found 
that this combined training is effective in reducing fatigue but not 
intense enough to improve impairments in manual dexterity suggesting 
to clinicians the provision of tailored and more intensive interventions is 
needed to reduce manual impairments.  
 
Since aerobic and task oriented training is suitable to improve upper and 
lower limb performances. We set up a further randomized controlled 
trial to evaluate the safety, feasibility and preliminary effects of a high-
intensity rehabilitative multimodal (aerobic and task oriented) training 
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protocol carried out on treadmill on mobility, balance, executive 
function and health-related quality of life in a sample of persons with 
moderate to severe MS mobility compared to a control group that 
received a strengthening program of similar intensity. Our results 
showed people in the treadmill group improved their gait resistance 
more than the strength training group and as a whole the group 
improved much more in gait resistance, speed and mobility. Factors to 
do with static and dynamic balance instead improved moderately in 
both groups while executive control and perception of health remained 
similar in both groups following training. 
 
Finally, we designed a longitudinal study aimed at verifying if the use of 
a device providing functional electrical stimulation was effective to 
improve walking endurance, reducing falls and improving lower limbs 
kinematics related to foot clearance and energy recovery assessed with 
instrumented gait analysis. A walking training protocol was set up and 
subjects were asked to walk wearing the device as long as possible. We 
found an improvement in gait resistance, reduction in number of falls 
and a specific increase of foot clearance during the swing phase of the 
gait. This effect was not accompanied with a reduction in the energetic 
expenditure during walking. 
 
 
Future studies 
 
From the present work findings, future studies could deeply investigate 
the impact of neurorehabilitation in MS and the role of specificity and 
intensity of rehabilitation in this population.  
In particular, from the physiological point of view since aerobic exercise 
has been shown to ameliorate the aerobic conditioning in PwMS, it will 
be interesting to study whether an aerobic training may also reverse the 
cardio-vagal autonomic damage.  
Further investigations are needed on the role of aerobic training as a 
“priming” technique to enhance the effects of rehabilitation evaluating 
motor behaviour, white matter microstructural and cortical plasticity 
changes.  
 
 
  
 
